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1. INTRODUCTION 
 
1.1 SALL family of proteins 
 
Members of the conserved spalt (sal) gene family encode zinc finger proteins and have been 
implicated in multiple developmental processes. The region-specific homeotic gene spalt (sal) 
plays an important role in specifying the head and tail regions of the Drosophila melanogaster 
embryo (Jürgens, 1988). SAL function also contributes to the development of the wing 
imaginal discs and wing patterning (de Celis, 1998), participates in the development of sensory 
organs in the thorax (de Celis, 1999), required for the specification and establishment of planar 
cell polarity in the D. melanogaster eye (Domingos et al., 2004) and suppresses the molecular 
pathway that establishes tracheal development in the D. melanogaster embryo (Kühnlein et 
al., 1996). The SAL protein is characterised by three C2H2 double zinc finger motifs (Fig. 1.1). 
 
COOHNH2  
Figure 1.1: Schematic representation of SAL protein structure. A typical SAL protein contains at least three 
widely spaced C2H2 double zinc finger (DZF) motifs (yellow) with single C2H2 zinc finger attached to the second 
domain (blue). In addition, all vertebrate SAL proteins have an additional N-terminal C2HC zinc finger (red). 
Glutamine rich region marked in blue. Zinc finger domains represented as ovals. 
 
An additional C2H2 zinc finger motif is attached to the second double zinc finger domain 
(Kühnlein et al., 1994), and all vertebrate SAL proteins have an additional N-terminal C2HC 
zinc finger. Each C-terminal zinc finger of the double zinc finger contains a conserved 
sequence called “SAL-box” which consists of eight conserved amino acids (FTTKGNLK). 
The SAL protein contains also some regions rich in glutamines, alanines, prolines and serines. 
C2H2 zinc finger domains are composed of 21 amino-acid residues including two conserved 
Cys and two conserved His residues which are coordinated by a zinc ion (Fig. 1.2). Zinc 
fingers have been found to bind to both RNA and DNA motives. 
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Cys HisCys His
Figure 1.2: Schematic representation of series of two zinc fingers #-X-C-X(1-5)-C-X3-#-X5-#-X2-H-X(3-6)-
[H/C]. Where X can be any amino acid, and numbers in brackets indicate the number of residues. The final 
position can be either His or Cys. 
 
The double zinc finger motifs are highly conserved among the D. melanogaster spalt and 
spalt-related proteins and vertebrate SALL (SAL-like) proteins. The strong conservation 
among SAL family members has allowed to identify the homologous genes in various species. 
One of the medaka (Oryzialis latipes) homologues of spalt was identified by Köster et al. 
(1997). Medaka sal is expressed in the eye, CNS, excretory system, the somites and the 
developing fins during embryogenesis and is controlled by the sonic hedgehog pathway 
(Köster et al., 1997). Three homologues of sal family were isolated in zebra fish (Danio 
rerio). Zebra fish sall1a and sall1b are orthologous to other vertebrate sall1 genes and zebra 
fish sall3 is orthologous to other sall3 vertebrate genes, except Xenopus sall3 (Camp et al., 
2003). sall1a and sall3 are expressed in various regions of the CNS, including in primary 
motor neurons. Outside of the CNS, sall1a expression was observed in the otic vesicle (ear), 
heart and in a discrete region of the pronephric ducts. Like other vertebrate sal genes, 
zebrafish sal genes have a role in neural development (Camp et al., 2003). Zebrafish sall4 
homologue is listed in the database, but no data are available on the expression and function. 
Xenopus laevis Xsal-1 encodes a protein with the structure similar to the Drosophila spalt, but 
contains additional double zinc finger domain (Holleman et al., 1996). During early 
development Xsal-1 expression is confined the midbrain, hindbrain, and spinal cord. Xsal-1 
expression was also found in the developing limb buds (Holleman et al., 1996). The pattern of 
expression suggests that Xsal-1 takes part in neuronal cell specification (Holleman et al., 
1996). Alternatively spliced Xsal-3 transcripts give rise to RNAs coding either two or three 
double zinc fingers, and the longer form is expressed maternally (Onuma et al., 1999). Xsal-3 
is expressed in the neural tube, the mandibular, hyoid, and branchial arch and the pronephric 
Zn2+ Zn2+
CysCys HisHis
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duct (Onuma et al., 1999). XsalF gene plays an essential role for the forebrain/midbrain 
determination and functions by antagonising canonical Wnt signalling pathway in Xenopus 
(Onai et al., 2004). A new member of the Xenopus sal family was recently identified 
(XlSALL4) by a competitive subtractive hybridization screen of genes expressed in Xenopus 
hindlimb regeneration blastemas (Neff et al., 2005). The expression pattern of XlSALL4 
transcripts was similar to Xsal-3 during embryonic development. XlSALL4 may regulate 
normal forelimb and hindlimb development and is necessary for the epimorphic limb 
regeneration (Neff et al., 2005). 
In the chick three members of the spalt family have been described so far, csal1, csal3 and 
csal4 (Sweetman et al., 2005, Farrell et al., 2001, Barembaum and Bronner-Fraser, 2004). 
During early embryonic development csal1 expression was found in ectoderm, involuting 
mesoderm and presegmented mesoderm. csal1 expression was also observed in the heart, the 
neural plate and the pharynx (Sweetman et al., 2005). At later developmental stages csal1 
transcripts were detected in the CNS, tail bud and developing limb buds and the csal1 
expression is regulated by members of the FGF and Wnt families (Farrell and Munsterberg, 
2000). csal3 is expressed in the nervous system, developing kidney, cloaca and limb bud 
(Farrell et al., 2001). csal4 is expressed in the neural tube, migrating neural crest and branchial 
arches and might be involved in the neural crest cell determination (Barembaum and Bronner-
Fraser, 2004). 
The mouse Sall as well as the human SALL families contain four members each. The murine 
homologue of the human SALL1 gene was isolated by Buck et al., 2000. Sall1 consists of three 
exons and SALL1 protein shares a high (89%) sequence homology with human SALL1. 
Northern blot analysis of Sall1 showed strong expression of Sall1 transcript in kidney. A 
lower amount of the transcript was found in brain, liver, testis, and heart tissue (Buck et al., 
2000). During embryonic development prominent Sall1 expression was found in the 
developing brain and the limbs. Other sites of expression include the meso- and metanephros, 
lens, olfactory bulbs, heart, primitive streak and the genital tubercle (Buck et al., 2001). Sall2 
consists of three exons (exons 1, 1a and 2) with 1 and 1a encoding alternative translational 
start sites. Sall2 encodes only three double zinc finger domains, the most carboxyterminal of 
which only distantly resembles spalt-like zinc fingers (Kohlhase et al., 2000b). Sall2 is 
expressed throughout embryonic development but also in adult tissues, predominantly in brain 
(Kohlhase et al., 2000b). Sall3 is expressed in the developing neuroectoderm of the brain, the 
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inner ear, the spinal cord, the testis, ovaries and kidneys. A weaker and transient expression 
was also observed in the branchial arches, the notochord, the limb buds and the heart (Ott et 
al., 1996). The mouse Sall3 locus is an epigenetic hotspot of aberrant DNA methylation 
associated with placentomegaly of cloned mice (Ohgane et al., 2004). 
SAL family members represent a group of evolutionary conserved zinc finger transcription 
factors which have been identified in many species and appear to be critical developmental 
regulators. Despite strong conservation among the family and partial overlapping expression 
pattern members of SALL family have some common and some unique functions during 
development. The summary of the known and predicted protein sequences of SALL family is 
presented on the figure 1.3. 
Hs SALL2 (1) 
Mm Sall2 (2) 
Bt SALL2 (3) 
Cf Sall2 (4) 
Xl XsalF (5) 
Hs SALL4 (6) 
Cf Sall4 (7) 
Bt SALL4 (8) 
Mm Sall4 (9) 
Xl Xsal-3 (10) 
Xl XlSALL4 (11) 
Gg csal4 (12) 
Dr sall4 (13) 
Tn sal (14)
Rn Sall1 (15) 
Mm Sall1 (16) 
Hs SALL1 (17) 
Cf Sall1 (18) 
Bt SALL1 (19) 
Gg csa1 (20) 
Dr sall1 
Hs SALL3 (22) 
Mm Sall3 (23) 
Gg csal3 (24) 
Xl Xsal-1 (25) 
Cf Sall3 (26) 
Dr sall3 (27) 
Ol sal (28) 
Dm spaltr (29) 
Dm spalt (30) 
Ce sem-4 (31) 
a (21) 
 
Figure 1.3: SAL protein family maximum parsimony phylogenetic tree. The phylogeny analysis was done by the 
ClustalW and TreeTop software. Species abbreviations: Bt, Bos taurus, Ce, Caenorhabditis elegans, Cf, Canis 
familiaris, Dm, Drosophila melanogaster, Dr, Danio rerio, Gg, Gallus gallus, Hm, Homo sapiens, Mm, Mus 
musculus, Ol, Oryzalis latipes, Rn, Rattus norvegicus, Tn, Tetraodon nigroviridis, Xl, Xenopus laevis. Accession 
numbers of the proteins: 1-NP_005398, 2-NP_056587, 3-XP_605967.2, 4-XP_539685.2, 5-AAS79482, 6-
NP_065169, 7-XP_543055, 8-XP_614880.1, 9-NP_780512, 10-BAA85900, 11-AAP97930, 12-AAR01968, 13-
XP_701344, 14-CAG03873, 15-XP_226329, 16-NP_067365, 17-NP_002959, 18-XP_544410, 19-XP_592327, 
20-NP_990038, 21-XP_683406, 22-NP_741996, 23-NP_840064, 24-NP_989978, 25-AAC42233, 26-
XP_848821, 27-XP_696441, 28-AAB51127, 29-NP_523548, 30-P39770, 31-NP_491997. 
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1.2 SALL genes and human syndromes 
 
The human SALL protein family includes four members. The gene SALL1 is localised on 
chromosome 16q12.1 and encodes a typical SAL-like protein with four double zinc finger 
domains of the SAL-type and an additional N-terminal C2HC zinc finger motive (Kohlhase et 
al., 1996). Strong expression of SALL1 was detected in adult kidney, brain and liver (Kohlhase 
et al., 1996). SALL1 localises to heterochromatic foci within the nucleus and acts as a strong 
transcriptional repressor in mammalian cells (Netzer et al., 2001). Mutations in SALL1 gene 
cause Townes-Brocks syndrome, a rare autosomal dominantly inherited malformation 
syndrome characterized by imperforate anus, dysplastic ears, and preaxial polydactyly and/or 
triphalangeal thumbs (Kohlhase et al., 1998). Less commonly TBS patients also show 
malformations of the feet, the kidneys, and the heart as well as hearing loss, impaired renal 
function, and mental retardation (Kohlhase et al., 1999a, Powell and Michaelis, 1999). The 
finding of disease-causing mutations of SALL1 in TBS suggested an important developmental 
regulatory function for SALL1 (Kohlhase et al., 1998). Most mutations causing TBS are 
clustered in the N-terminal third of the SALL1 coding region and result in the production of 
truncated proteins containing only one or none of the C2H2 domains and the N-terminal 
transcriptional repressor domain of SALL1 (Botzenhart et al., 2005). Two other members of 
SAL-family, SALL2 (Kohlhase et al., 1996) and SALL3 (Kohlhase et al., 1999b), have not 
been found yet to cause disease phenotype, but an involvement of SALL2 has been discussed 
in ovarian carcinoma (Li et al., 2001) and SALL3 haploinsufficiency was thought to contribute 
to the phenotype of patients with terminal deletions of chromosome 18q (Kohlhase et al., 
1999b). 
Mutations in the SALL4 gene result in Okihiro/Duane-radial ray syndrome (DRRS) syndrome 
(Kohlhase et al., 2002b), an autosomal dominant condition characterised by radial ray defects 
and Duane anomaly (Fig 1.4). Other abnormalities reported in this condition are anal, renal, 
cardiac, ear, foot malformations and hearing loss (Kohlhase et al., 2002b, Al-Baradie et al., 
2002, Kohlhase et al., 2003, Borozdin et al., 2004a). SALL4 mutations may also cause acro-
renal-ocular syndrome (AROS), which differs from DRRS by the presence of structural eye 
anomalies, and phenotypes similar to thalidomide embryopathy and Holt-Oram syndrome 
(HOS) (Borozdin et al., 2004b). 
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Figure 1.4: Clinical features of Okihiro syndrome patients. (A, B) Family demonstrating Duane retraction 
anomaly. The patients are unable to abduct the left eye unilaterally and on adducting the same eye there is 
retraction of the globe and narrowing of the palpebral fissure. (C–F) Limb malformations in three affected 
individuals. (C) Patient has bilateral radial club hands with absence of the thumbs. (D) Patient has a normal 
humerus but short forearm and absence of the thumb. (E) There is radiological fusion of the ulna and radius, 
which are foreshortened. The first metacarpals are absent. (F) Patient shows a very rudimentary upper limb, with 
absence of the thumb and forearm and a short humerus (pictures from: Kohlhase et al. (2002a). Okihiro syndrome 
is caused by Sall4 mutations. Hum Mol Genet (11) published by Oxford University Press). 
 
The human SALL4 gene is localised on chromosome 20q13.13-q13.2 (Kohlhase et al., 2002a, 
Al-Baradie et al., 2002). SALL4 consists of 4 exons with an open reading frame of 3159 bp. It 
encodes a protein with three C2H2 double zinc finger domains second of which has a single 
C2H2 zinc finger attached at its carboxy-terminal end, as well as an N-terminal C2HC zinc 
finger motif typical for vertebrate SAL-like proteins (Fig 1.5). It expressed in several human 
tissues including testes, ovary and spleen as determined by Kohlhase et al. (2002a). It also 
expressed in the embryonal carcinoma cell lines H12.1 and 2102EP as shown by Kohlhase et 
al. (2002a). 17 of the 22 SALL4 mutations known to date are located in exon 2, and five are 
located in exon 3 (Fig 1.5). These are nonsense mutations, short duplications, and short 
deletions. All of the mutations lead to preterminal stop codons and are thought to cause the 
phenotype via haploinsufficiency (Kohlhase et al., 2005). 
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Figure 1.5: Schematic representation of the SALL4 protein and localization of the mutations and deletions 
identified to date. Zinc fingers are indicated as oval symbols. SALL4 encodes three C2H2 double zinc finger 
domains distributed over the protein. A single C2H2 domain is attached to the second double zinc finger. At the 
aminoterminus, a single C2HC domain is found. Horizontal bars indicate the positions of bigger deletions with 
respect to the coding exons. The interrupted bar indicates that this deletion spares exon 4 but continues farther 30. 
Note that the mutations c.496 dupC and c.2593C4T have each been found in two unrelated families. All other 
mutations have been found only once. The newly described mutations are labelled, and the unlabeled arrows 
represent previously described mutations. Positions of the introns are indicated. Numbers refer to the amino acid 
sequence (1053 aa). (pictures from: Kohlhase et al. (2005). SALL4 mutations in Okihiro syndrome (Duane-radial 
ray syndrome), acro-renal-ocular syndrome, and related disorders. Hum Mutat (26) published by Wiley-Liss, 
Inc.). 
 
The only missense point mutation of the SALL4 gene known to date, (c.2663A→G, p.H888R) 
positioned within the first C2H2 zinc finger of the C–terminal double zinc finger motif in the 
SALL4 gene, was investigated by a molecular modelling study on the wild type and mutated 
zinc finger domains (Frecer et al., 2004). The modelled wild type and mutated forms of zinc 
finger motif of the SALL4 did not display significant structural differences caused by steric 
strain or charge of R888. However, more significant differences were predicted in their 
binding affinities to DNA. Calculated higher DNA binding affinity of the mutated zinc finger 
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could alter activator/repressor function or the cause for erroneous targeting of a different DNA 
sequence (Frecer et al., 2004). 
Up to now four murine homologues of human SALL family have been reported (Buck et al., 
2000, Kohlhase et al., 2000b, Ott et al., 1996, Kohlhase et al., 2002b). The Sall4 gene was 
isolated based on the high sequence homology (72%) to human SALL4. During embryonic 
development Sall4 expression was found in the brain, branchial arches and limbs suggesting 
an important role of Sall4 during development (Kohlhase et al., 2002b). 
 
1.3 Mice as model organisms for human diseases  
 
Among the model organisms, the mouse offers particular advantages for the study of human 
biology and disease. 
• The mouse is a mammal, and its development, body plan, physiology, behaviour and 
diseases have much in common with those of humans 
• Almost all (99%) mouse genes have homologues in humans 
• The mouse genome supports targeted mutagenesis in specific genes by homologous 
recombination in embryonic stem (ES) cells, allowing genes to be altered efficiently and 
precisely (Austin et al., 2004) 
Many models for genetic diseases were established through spontaneous mutations. Another 
way to produce mouse lines for the different genetic diseases is by targeted disruption of a 
specific gene which is responsible for the human syndrome. Various methods can be used to 
create mutated alleles, including gene targeting, gene trapping and RNA interference. 
• Knockout technology is based on the homologous recombination of the targeting 
vector with genomic sequence in mouse ES cell (Smithies et al., 1985). Advantages of 
this method include flexibility in design of alleles, possibility to produce reporter knock-
ins and conditional alleles and ability to target splice variants and alternative promoters. 
Some important limitations exist, like the gene may serve a different function in human 
than in mouse, about 15% of knockouts are developmentally lethal and the procedure is 
laborious and costly. The total number of knockout mice described in the literature is 
around 2500 unique genes (Austin et al., 2004) 
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Recent advances in RNA interference (RNAi) technology have provided a rapid loss-of-
function method for assessing gene function in a number of organisms (Prawitt et al., 
2004). Plasmid-based systems using H1 or U6 RNA polymerase III promoters driving 
expression of short hairpin RNA (shRNA) molecules were stably integrated into the 
genome of mice by microinjecting DNA into one cell mouse embryos or transecting ES 
cells (Hasuwa et al., 2002, Kunath et al., 2003). The desired knock-down phenotype was 
apparent and transmitted to the germline. Drawbacks of using this technology are cross-
hybridisation of siRNA with similar sequences which lead to multiply gene phenotype, 
constitutive RNAi expression in knock-down mice which might provoke an embryonic 
lethal phenotype. 
 
1.4 Gene trap approach
 
Gene trapping is a high-throughput approach that can be used to introduce insertional 
mutations across the genome in mouse embryonic stem (ES) cells (Hansen et al., 2003, 
Skarnes et al., 2004). Gene trap mutagenesis of mouse ES cells generates random loss-of-
function mutations, which can be identified by a sequence tag and can often report the 
endogenous expression of the mutated gene (Wurst et al., 1995). 5’ RACE is used to analyse 
genes trapped by all types of vectors. The gene trap vector pT1betageo used in this study 
contains the engrailed-2 splice acceptor site fused to the promoterless LacZ reporter gene (Fig. 
1.6). Integration of pT1betageo into the intron of an active gene can generate a fusion 
transcript between LacZ and an endogenous trapped gene. The bacterial resistance is 
supported by neomycin cassette driven by the PGK-1 promoter and containing an SV-40 
polyadenylation signal. 
 
 
Figure 1.6: Schematic representation of the pT1ßgeo gene trap vector used in this study. En2in- engrailed-2 
intron; En2ex- engrailed-2 exon; βgeo, a fusion gene between the β-galactosidase (βgal) and neomycin 
phosphotransferase (neo) genes; pA, SV40 polyadenylation signal. 
 
 pT1ßgeo pA ßgeo En2in En2ex 
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Gene trap ES cell lines are available at the different sources like German Gene Trap 
Consortium (http://www.genetrap.de), the Mammalian Functional Genomics Centre 
(http://www.escells.ca), the Sanger Institute Gene Trap Resource 
(http://www.sanger.ac.uk/genetrap) and others. Mutated ES cell clones could serve as a 
resource to accelerate genome annotation and the in vivo modeling of human disease. 
 
1.5 Mouse models for Sall gene function 
 
Recent studies have provided new insights into a putative role of SALL proteins 
(Nishinakamura et al., 2001, Sato et al., 2004). Generation of mice lacking Sall genes is 
necessary to address developmental role of Sall family. Several mouse models were created to 
study the function of sal-like genes in mouse and human, including Sall1 (Nishinakamura et 
al., 2001, Kiefer et al., 2003), Sall2 (Sato et al., 2003), Sall3 (Parrish et al., 2004). Sall1 is 
expressed in the metanephric mesenchyme surrounding uteric bud, and homozygous deletion 
of Sall1 results in an incomplete uteric bud outgrowth and failure of tubule formation in the 
mesenchyme (Nishinakamura et al., 2001). Loss of the Sall1 gene cause perinatal death in 
mice because of kidney agenesis or severe dysgenesis (Nishinakamura et al., 2001). No other 
abnormalities in Sall1-deficient mice were found. Another mouse model which mimics the 
phenotype of TBS patients was described by Kiefer et al. (2003). Mice, expressing Sall1 
transcriptional repression domain and lacking the DNA binding domain recapitulate the 
abnormalities found in human TBS. Sall1 heterozygous mice display hearing loss, renal cystic 
hypoplasia and wrist abnormalities. Homozygous mutant mice have renal agenesis, 
exencephaly, limb and anal deformities (Kiefer et al., 2003). Murine Sall2 has an overlapping 
expression pattern with Sall1, but Sall2 knockout mice show no apparent abnormal phenotype 
(Sato et al., 2003). Sall3 homozygous mutant mice die on the first postnatal day and fail to 
feed because of palate and epiglottis anomalies and glossopharyngeal nerve (IX) deficiency 
(Parrish et al., 2004). 
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1.6 Aims of the study 
 
Preceding the presented study a Sall4 mouse gene trap line was identified by comparing Sall4 
sequences to the database of the German Gene Trap Consortium. The present study aimed at 
characterizing this mutant in detail. Specifics were: 
1) to identify and characterize potential Sall4 isoforms 
2) to characterize the mutation and the phenotype of the Sall4 gene trap line 
3) to perform detailed expression studies of Sall4 during embryonic development 
4) to analyze Sall4 regulation during embryonic development 
5) to generate a specific antibody against Sall4 
6) to perform protein interaction studies of Sall4 and Sall1 
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2. MATERIALS AND METHODS 
 
2.1 Materials 
 
2.1.1 Chemicals 
 
1 kb DNA Ladder    Invitrogen, Karlsruhe 
Acetic acid     Merck, Darmstadt 
Acrylamide/Bisacrylamide   Roth, Karlsruhe 
Agar      Roth, Karlsruhe 
Agarose     Invitrogen, Karlsruhe 
Alkaline phosphatase    Invitrogen, Karlsruhe 
Ammonium acetate    Fluka, Neu Ulm 
Ampicillin     Sigma, Deisenhofen 
Ampuwa     Fresenius, Bad Homburg 
Aprotinin     Sigma, Deisenhofen 
BCIP      Applichem, Darmstadt 
Boric acid     ICN Biomedicals, Eschwege 
Bromophenolblue    Sigma, Deisenhofen 
BSA      Biomol, Hamburg 
Cell culture media (DMEM)   PAN-Systems, Nürnberg 
Chloroform     Merck, Darmstadt 
Coomasie G-250    Sigma, Deisenhofen 
DEPC      Sigma, Deisenhofen 
Dithiothreitol     Sigma, Deisenhofen 
DMSO      Merck, Darmstadt 
DNA Marker     Invitrogen, Karlsruhe 
dNTPs (100 mM)    Invitrogen, Karlsruhe 
EDTA      ICN Biomedicals, Eschwege 
EGTA      Applichem, Darmstadt 
Ethanol     Merck, Darmstadt 
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Ethidium bromide    Eurobio, Les Ulis Cedex 
FBS      PAN-Systems, Nürnberg 
Ficoll 400     Applichem, Darmstadt 
Formaldehyde     Merck, Darmstadt 
Formamide     Sigma, Deisenhofen 
Glutaraldehyde    Sigma, Deisenhofen 
Glycerol     Merck, Darmstadt 
Glycine     Merck, Darmstadt 
Goat serum     PAN-Systems, Nürnberg 
H2O2        Merck, Darmstadt 
HCl      Merck, Darmstadt 
HEPES     Sigma, Deisenhofen 
IPTG      Applichem, Darmstadt 
Isopropanol     Merck, Darmstadt 
K3[Fe(CN)6]     Sigma, Deisenhofen 
K4[Fe(CN)6]     Sigma, Deisenhofen 
Kanamycin     Sigma, Deisenhofen 
KCl      Merck, Darmstadt 
KH2PO4     Merck, Darmstadt 
Leupetin     Sigma, Deisenhofen 
Lipofectamine 2000    Invitrogen, Karlsruhe 
M16 medium     Sigma, Deisenhofen 
Methanol     Merck, Darmstadt 
2-Mercaptoethanol    Serva, Heidelberg 
MgCl2      Merck, Darmstadt 
Milk powder     Roth, Karlsruhe 
Mineral oil     Sigma, Deisenhofen 
MOPS      Applichem, Darmstadt 
Na2HPO4     Merck, Darmstadt 
NaCl      Roth, Karlsruhe 
NaH2PO4     Merck, Darmstadt 
NaN3      Merck, Darmstadt 
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NaOH      Merck, Darmstadt 
NBT      Applichem, Darmstadt 
Nonidet P40     Fluka, Neu Ulm 
NuPAGE MES SDS running buffer  Invitrogen, Karlsruhe 
NuPAGE SDS sample buffer   Invitrogen, Karlsruhe 
Orange G     Sigma, Deisenhofen 
Paraformaldehyde    Merck, Darmstadt 
PBS      PAN-Systems, Nürnberg 
Penicillin/Streptomycin   PAN-Systems, Nürnberg 
Peptone     Roth, Karlsruhe 
PfuI polymerase    Promega, Mannheim 
Phenol      Biomol, Hamburg 
Picric acid     Fluka, Neu Ulm 
Platinum Taq polymerase   Invitrogen, Karlsruhe 
Proteinase K     Roth, Karlsruhe 
RNase A     Qiagen, Hilden 
RNAse away     Applichem, Darmstadt 
RNase Inhibitor    Boehringer, Mannheim 
S.O.C Medium    Invitrogen, Karlsruhe 
Salmon sperm DNA    Sigma, Deisenhofen 
SDS      Serva, Heidelberg 
SeeBlue Plus2 protein marker  Invitrogen, Karlsruhe 
Sodium acetate    Merck, Darmstadt 
Sodium citrate     Merck, Darmstadt 
Sodium deoxycholate    Sigma, Deisenhofen 
Sucrose     Fluka, Neu Ulm 
SuperScript II     Invitrogen, Karlsruhe 
T4 DNA ligase    Promega, Mannheim 
TEMED     Merck, Darmstadt 
TRIreagent     Sigma, Deisenhofen 
Tris      Roth, Karlsruhe 
Triton X-100     Serva, Heidelberg 
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Trypsin     PAN-Systems, Nürnberg 
Tween-20     Promega, Mannheim 
Vectashield (DAPI)    Vector, Burlingame 
X-Gal      Applichem, Darmstadt 
Xylene      Merck, Darmstadt 
Yeast extract     Roth, Karlsruhe 
 
All chemicals not mentioned above were ordered from Merck, Darmstadt, or Roth, Karlsruhe. 
 
2.1.2 Solutions, buffers and media 
 
All standard buffers and solutions were prepared according to Sambrook et al. (1989). 
5x TBE buffer    450 mM Tris 
450 mM Boric acid 
20 mM EDTA (pH 8.0) 
 
Stop-mix    15% Ficol 400 
200 mM EDTA (pH 8.0) 
0.025% Orange G 
1% Glycerol 
 
APS solution    10% Ammoniumpersulfate in H2O 
 
Stacking gel buffer (4x)  0.5 M Tris/HCl (pH 6.8) 
0.4% SDS 
 
Separating gel buffer (4x)  1.5 M Tris/HCl (pH 8.3) 
0.4% SDS 
 
Coomassie Blue   0.25% Coomassie Brilliant Blue R-250 
(staining solution)   45% Methanol 
10% Acetic acid 
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Coomassie Blue   45% Methanol 
(destaining solution)   10% Acetic acid 
 
NBT solution    75 mg/ml NBT 
in 70% DMF 
 
BCIP solution    5% w/v 
in 100% DMF 
 
Denhardt´s solution (50x)  1% BSA 
1% Polyvinylpyrrolidone 
1% Ficoll 400 
 
dNTP-Mix (2 mM)   2 mM dATP 
2 mM dGTP 
2 mM dCTP 
2 mM dTTP 
 
Sodium phosphate buffer (NaP) 0.5 M NaH2PO4 (pH 7.4) 
 
GSDB     30% goat serum 
(Goat serum dilution buffer)  20 mM NaP buffer 
(blocking solution)   450 mM NaCl 
     0.3% Triton X-100 
 
GSDB     3% goat serum 
(antibody solution)   20 mM NaP buffer 
     450 mM NaCl 
     0.1% Triton X-100 
 
Lysis buffer (pH 8.0)   100 mM Tris 
(bacterial cells)   500 mM NaCl 
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0.5 mM EDTA 
0.1% Triton X-100 
0.1% Tween 20 
250 mM Urea 
5 mM β-Mercaptoethanol 
0.03% DTT 
5% Glycerol 
     1 mM PMSF 
 
Tissue lysis buffer   10 mM Tris/HCl (pH 8.0) 
     1 mM EDTA 
     2.5% SDS 
     1 mM PMSF 
 
PBS buffer    140 mM NaCl 
8 mM Na2HPO4
2 mM KH2HPO4
2.7 mM KCl 
 
PBT buffer    0.1% Tween 20 
in PBS 
 
20x SSC    3 M NaCl 
0.3 M Sodium citrate (pH 7.0) 
 
2.1.3 Laboratory materials 
 
The laboratory materials, which are not listed here, were bought from Schütt and Krannich, 
Göttingen. 
 
Cell culture flask   Greiner, Nürtingen  
Culture slides    BD Falcon, Heidelberg 
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Disposable filter Minisart  NMI Sartorius, Göttingen 
Filter paper 0858   Schleicher and Schüll, Dassel 
Hybond – C    Amersham, Braunschweig 
HPTLC Aluminum folio  Merck, Darmstadt 
Microcentrifuge tubes   Eppendorf, Hamburg 
Petri dishes    Greiner, Nürtingen 
Pipette tips    Eppendorf, Hamburg 
RotiPlast paraffin   Roth, Karlsruhe 
Superfrost slides   Menze, Gläser 
Whatman blotting paper  Schleicher and Schüll, Dassel 
X-ray films    Amersham, Braunschweig 
 
2.1.4 Sterilisation of solutions and equipments 
 
All solutions that are not heat sensitive were sterilised at 121°C, 105 Pa for 60 min in an 
autoclave (Webeco, Bad Schwartau). Heat sensitive solutions were filtered through a 
disposable sterile filter (0.2 to 0.45 µm pore size). Plastic wares were autoclaved as above. 
Glassware were sterilised overnight in an oven at 220°C. 
 
2.1.5 Media, antibiotics and agar-plates 
 
2.1.5.1 Media for bacteria 
 
LB Medium (pH 7.5):   1% Peptone 
0.5% Yeast extract 
1% NaCl 
 
LB-Agar:    1% Peptone 
0.5% Yeast extract 
1% NaCl 
1.5% Agar 
The LB medium was prepared with distilled water, autoclaved and stored at 4°C. 
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2.1.5.2 Media for cell culture 
 
ES-cell medium: 
DULBECCO´s Modified Eagles Media 0.1 mM Non essential amino acids 
(DMEM) with     1 mM Sodium pyruvate 
10 µM ß-Mercaptoethanol 
2 mM L-Glutamine 
20% Fetal calf serum (FCS) 
1000 U/ml Recombinant leukaemia inhibitory 
factor 
 
Cell medium: 
DULBECCO´s Modified Eagles Media 2 mM L-Glutamine 
(DMEM) with     1% penicillin/streptomycin 
10% Fetal calf serum 
 
Freezing medium:    20% Fetal calf serum 
10% DMSO 
in DMEM 
 
2.1.5.3 Antibiotics 
 
The stock solutions were filtered through sterile disposable filters and stored at -20°C. When 
antibiotics were needed, in each case it was added after the autoclaved medium has cooled 
down to a temperature lower than 55°C. 
 
 Stock solution Working solution 
Ampicillin 50 mg/ml 50 µg/ml 
Kanamycin 25 mg/ml 50 µg/ml 
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2.1.5.4 IPTG/X-Gal LB agar 
 
LB-agar with 50 µg/ml ampicillin, 1 mM IPTG and 2% X-Gal was poured into Petri dishes. 
The dishes were stored at 4°C. 
 
2.1.6 Bacterial strains 
 
Competent cells E. coli DH5α These cells were used for plasmid transformation 
(Invitrogen)  
Competent cells E. coli BL21 (DE3) These cells were used for expression of recombinant 
(Novagen) proteins 
 
2.1.7 Plasmids 
 
pBluescript KS (+/-)  Stratagene 
pGEM-T Easy   Promega, Mannheim 
pEGFP-C1   BD Clontech, Heidelberg 
pET41a   Novagen, San Diego 
pcDNA myc-His 3.1A Invitrogen 
 
2.1.8 Synthetic oligonucleotide primers 
 
The synthetic oligonucleotides used in this study were ordered from Eurogentec (Köln, 
Germany), Roth (Karlsruhe, Germany), Operon (Hilden, Germany), and Invitrogen 
(Karlsruhe, Germany). The oligonucleotides were dissolved in water to a stock concentration 
of 100 pmol/µl. 
 
E1aRTF1 5' CGGACTGCGACACACACC 3' 
E2RTR1 5' AGAACTCGGCACAGCATTT 3' 
E1RTF1 5' GAAGCCCCAGCACATCAAC 3' 
E2RTR2 5' CTGAGGCTTCATCGCAGTT 3' 
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actinF  5' CTTTGCAGCTCCTTCGTTGC 3' 
actinR  5' ACGATGGAGGGGAATACAGC 3' 
dom1F1 5' ACGGAATTCTGTTCTCAGGATGTTCCCAGTG 3' 
dom1R1 5' GGACTCGAGGGAAGTGAGGGAACTGGTGT 3' 
S4E1aF3 5' AGTTTTCTGCGGATCACTCG 3' 
S4E3F  5' GGAGAGAAGCCTTTCGTGTGT 3' 
S4E4R  5' GTTCTCTATGGCCAGCTTCCT 3' 
pTKneoF264 5' GGCTGACCGCTTCCTCGTG 3' 
Ex2F164 5' TGATTACACGACATTTCCTACTG 3' 
SAR364 5' CTCTTCTTCCTGGCTAACTCG 3' 
S4E2RTF1 5' TCTCCCCAACTTCGTGTCTC 3' 
S4E3RTR1 5' GGCTGTGCTCGGATAAATGT 3' 
Sp6  5' TTTAGGTGACACTATAGAA 3' 
T7  5' AATACGACTCACTATAGGG 3' 
S1F1new 5' AGTAAGCTTCGGAAGAGGGAGTACAGGGC 3' 
S1pcDNAtrR 5' TATTCTAGAAGTGACATTTGGTGGGTTGC 3' 
brachyuryF 5' CTGCGCTTCAAGGAGCTAAC 3' 
brachyuryR 5' CCCCGTTCACATATTTCCAG 3' 
Tbx1F  5' CGACAAGCTGAAACTGACCA 3' 
Tbx1R  5' GTGACTGCAGTGAAGCGTGT 3' 
Tbx5F  5' ATATTGTTCCCGCAGACGAC 3' 
Tbx5R  5' TTGAGCTTCTGGAAGGAGACA 3' 
Sall1seq 5' TGGGCATCCTTGCTCTTAGT 3' 
S4ME2R3 5' CAGTAATCAATTCCCCATCAGC 3' 
S4ME2R2 5' GAAAGGAGAGAAAAAGGTGAGC 3' 
S4ME2R1 5' AGGGGAGTTCACTGGAGCAC 3' 
S4ME1F1 5' GGCTAAAATTTCCCAACTCCAG 3' 
S4ME1F2 5' CAGGAATTGGTGGCGGAGAG 3' 
S4ME1F3 5' GCACCATGTCGAGGCGCAAG 3' 
pGeoR1 5' AAGGCGATTAAGTTGGGTAACG 3' 
pGeoR2 5' ATGGAGGAGAAAGGGCAGAGG 3' 
pGeoF1 5' ATCAGCCGCTACATGCAACAG 3' 
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pGeoF2 5' ATTGGTGGCGACGACTCCTG 3' 
S4MI1R1 5' GTGAAGGAAGCCCAAGTTACC 3' 
S4MI1R2 5' CCGACCTCTCCCCTTTCACC 3' 
S4MI1F4 5' TGCCTCTCCCTCCAACTTCTC 3' 
S4MI1F5 5' ATGTGAGTTTTGGGGCGTTGG 3' 
S4MI1F6 5' AAAAAATCCGCAGGTGGTCAAG 3' 
S4MI1F7 5' TGGGTTTCTTTATTGGGGTTAC 3' 
S4MI1F8 5' ATAACTAGATGCTGAAGAGATACC 3' 
S4MI1F9 5' ACTAGGTAGGCATCAGGTAAAAC 3' 
S4MI1F10 5' GTTTCTCTTAGTATAGCCCCAG 3' 
S4MI1F11 5' ATCCCCTAGACTTACTGTTGAG 3' 
S4MI1F12 5' ATTCTGCACTTGGGAGGATGAG 3' 
S4MI1F13 5' TTTCCATTTCGCCTGTGTCGTG 3' 
S4MI1F14 5' AATTCTTCTTCTTGGAGTGATGC 3' 
pGeoR3 5' GTCACTCCAACGCAGCACCATCACC 3' 
pGeoR4 5' TGCCAGTTTGAGGGGACGACGACAG 3' 
pGeoF3 5' GAAAACTATCCCGACCGCCTTACTGC 3' 
pGeoF4 5' CATATGGGGATTGGTGGCGACGACTC 3' 
S4ME1F4 5' TAGTGGCCGCAAGGATGATTC 3' 
S4MI1F1 5' TGGGGATTCCGGACTCTGTTC 3' 
S4MI1F2 5' CAGGAAAGGAGAGATGCGGAG 3' 
S4I1R1a 5' TTTAAAAGCGGCGCCACTAGA 3' 
S4E1aRTF1 5' AAGCGAGTTTTCTGCGGATCAC 3' 
S4E1aRTF2 5' CGGACTGCGACACACACCTG 3' 
S4MRTR3 5' AGGGCACTGGGAAGGCGAGAC 3' 
pGeoR7 5' CCACAACCAACGCACCCAAGC 3' 
pGeoR6 5' GAGATGGATTGGCAGATGTAGC 3' 
pGeoR5 5' TGCATTTGTTTTTCTCCCCTTATC 3' 
S4E1aF3 5' AGTTTTCTGCGGATCACTCG 3' 
Sall4ORF1f 5' GGGGCTAAAATTTCCCAACT 3' 
Sall4ORF1r 5' GGGAACTCTGACAGCTGAGG 3' 
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Sall4ORF2f 5' GGCTACCTCAAAAGCTCACG 3' 
Sall4ORF2r 5' ATCTCCCTGCAGAAGACTCC 3' 
 
2.1.9 Eukaryotic cell lines 
 
NIH3T3   Mouse embryonic fibroblast cell line, ATCC, Rockville, USA 
F9    Mouse teratocarcinoma cell line, ATCC, Rockville, USA. 
 
2.1.10 Mouse strains 
 
Mouse strains C57BL/6J, 129X1/SvJ, CD-1 and NMRI were initially ordered from Charles 
River Laboratories, Wilmington, USA, and further bred in the animal facility of the Institute 
of Human Genetics, Göttingen. 
 
2.1.11 Antibodies 
 
Goat anti-rabbit IgG alkaline phosphatase conjugate  Sigma, Deisenhofen 
Goat anti-mouse IgG alkaline phosphatase conjugate Sigma, Deisenhofen 
Goat anti-rabbit IgG Cy3 conjugate    Sigma, Deisenhofen 
Rabbit anti-mouse IgG FITC conjugate   Sigma, Deisenhofen 
Goat anti-rabbit IgG FITC conjugate    Sigma, Deisenhofen 
Mouse monoclonal anti-E2 (977)    Abcam, Cambridge 
Rabbit polyclonal anti-c-Myc     Sigma, Deisenhofen 
Mouse monoclonal anti-c-Myc    Roche, Mannheim 
Mouse monoclonal Penta-His     Qiagen, Hilden 
Rabbit polyclonal anti-Sall4     generated in the present study 
Rabbit polyclonal anti-GST     Novagen, San Diego 
Mouse monoclonal anti-α-tubulin    Sigma, Deisenhofen 
Sheep anti-Digoxigenin-AP, Fab fragments   Roche, Mannheim 
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2.1.12 Kits 
 
Lipofectamin2000      Invitrogen, Karlsruhe 
DYEnamic ET-Terminator mix    Amersham, Freiburg 
Midi Plasmid Kit      Qiagen, Hilden 
QIAquick Gel Extraction Kit     Qiagen, Hilden 
SulfoLink Kit       Pierce, Bonn 
Wizard® SV Gel and PCR Clean-Up System  Promega, Mannheim 
Montage PCR       Millipore, Schwalbach  
QuantiTest SYBR Green PCR Master Mix    Qiagen, Hilden 
pGEM T-easy vector system     Promega, Mannheim 
SuperScript II       Invitrogen, Karlsruhe 
 
2.1.13 Instruments 
 
ABI Prism Real-Time detection system 7900  Applied Biosystems, Foster City 
Autoclave       Webeco, Bad Schwartau 
Biofuge 13       Heraeus, Hanau 
Centrifuge 5415 D      Eppendorf, Hamburg 
Centrifuge 5417 R       Eppendorf, Hamburg 
GeneAmp PCR System 9700     Perkin Elmer, Boston 
Histocentre 2 embedding machine    Thermo, Dreieich 
MegaBace Sequencer      Amersham, Freiburg 
Megafuge 1.0 R      Heraeus, Hanau 
Microscope BX60      Olympus, Hamburg 
Microscope BZX12      Olympus, Hamburg 
Microtom Hn 40 Ing.      Leica, Solms 
Neubauer cell chamber     Schütt Labortechnik, Göttingen 
Power supply       Gibco BRL, Karlsruhe 
Refrigerated Superspeed Centrifuge RC-5B   Sorvall, Langenselbold 
Semi-Dry-Blot      Biometra, Göttingen 
Spectrophotometer Ultraspec 3000    Amersham, Freiburg 
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SpeedVac concentrator SVC 100H    Schütt Labortechnik, Göttingen 
Thermocycler PTC-100     MJ Reseach, Waltham 
Thermomixer 5436      Eppendorf, Hamburg 
UV StratalinkerTM 1800     Leica, Solms 
 
2.2 Methods 
 
2.2.1 Isolation of nucleic acids 
 
2.2.1.1 Small-scale isolation of plasmid DNA (mini-prep) 
(Sambrook et al., 1989) 
 
A single E.coli colony was inoculated in 5 ml of LB medium with the appropriate antibiotic 
and incubated in shaker for 16 hrs at 37°C at speed of 150 rpm. Seven hundred microliters of 
the bacterial culture were used for preparation of glycerol stocks (0.7 ml of culture and 0.3 ml 
of glycerol). A 1.5 ml aliquot of the bacterial culture was centrifuged at 5000xg for 5 min. The 
pellet was resuspended in 150 µl of P1 solution. The bacterial cells were then lysed with 300 
µl of P2 solution and incubated for 5 min with 200 µl of P3 solution. The precipitated solution 
was centrifuged at 12000xg for 15 min at 4°C. The supernatant was transferred into a new 
tube and centrifugation was repeated. The supernatant was transferred into a new tube and 0.5 
ml of isopropanol was added to precipitate the DNA. It was then stored on ice for 15 min, 
centrifuged at full speed for 20 min, and finally the pellet was washed with 70% ethanol and 
after air-drying, the pellet was dissolved in 30 µl of sterile water. 
 
P1:   50 mM Tris/HCl (pH 8.0) 
10 mM EDTA 
100 µg/ml RNase A 
 
P2:   200 mM NaOH, 
1% SDS 
 
P3:   3.0 M potassium acetate (pH 5.5) 
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2.2.1.2 Large-scale preparation of plasmid DNA (midi-prep) 
 
A single clone was inoculated in 2 ml LB medium with appropriate antibiotic as a pre-culture 
for 8 hrs in 37°C shaker. This pre-culture was further inoculated at dilution of 1:100 in 100 ml 
LB medium with appropriate antibiotic and was cultured overnight at 37°C. The bacterial 
culture was then centrifuged at 6000xg for 15 min. The pellet was resuspended in 4 ml of P1 
solution and cells were then lysed by adding 4 ml of P2 and further incubating for 5 min at 
RT. The lysed culture was precipitated by adding 4 ml of P3 solution and incubating on ice for 
15 min. The precipitated solution was centrifuged at 12000xg for 30 min at 4°C. During this 
time the column (Qiagen-tip), which was provided with the midi preparation kit, was 
equilibrated with 10 ml of QBT solution. After centrifugation the lysate was passed through 
the equilibrated column thus allowing the DNA to bind with the column resin. The bound 
DNA in the column was then washed twice with 10 ml of QC solution. Finally, the DNA was 
eluted with 5 ml of QF solution. To precipitate the DNA, 3.5 ml of isopropanol was added, 
mixed thoroughly and centrifuged at 14000xg for 30 min at 4°C. The DNA pellet was washed 
with 70% ethanol, air-dried and dissolved in 100 µl of H2O. 
 
QBT:    750 mM NaCl  
50 mM MOPS (pH 7.0)  
15% Ethanol  
0.5% Triton X-100 
 
QC:    1 mM NaCl 
50 mM MOPS (pH 7.0)  
15% Ethanol 
 
QF:    1.25 M NaCl 
50 mM Tris/HCl (pH 8.5) 
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2.2.1.3 Isolation of genomic DNA from tissue samples 
 
Lysis buffer I:   100 mM Tris/HCl (pH 8.0) 
100 mM NaCl 
100 mM EDTA 
0.5% SDS 
 
The method was performed according to Laird et al. (1991). Mouse tail or tissue biopsies were 
incubated each in 700 µl of lysis buffer I containing 30 µl Proteinase K (10 µg/µl) at 55°C for 
overnight in a thermomixer. To the tissue lysate, equal volume of phenol was added, mixed by 
inverting several times, and centrifuged at 14000xg for 5 min. After centrifugation the upper 
aqueous layer was transferred into a new tube. Similar extraction procedure was also 
performed with phenol-chloroform (1:1 ratio) and followed with chloroform extraction. 
Finally, the DNA was precipitated with 0.7 volumes of isopropanol, and the DNA pellet was 
subsequently washed with 500 µl of 70% ethanol. The DNA was resuspended in 100-200 µl of 
sterile H2O and dissolved by incubation at 60°C for 20 min, for long term storage the DNA 
samples were stored at 4°C. 
 
2.2.1.4 Isolation of genomic DNA from mouse embryos 
 
Lysis buffer II   20 mM Tris-HCl 
    50 mM KCl 
    0.45% NP40 
    0.45% Tween-20 
    200 µg/ml Proteinase K 
 
Mouse embryos E7.5-E8.5 were dissected in cold PBS and washed briefly two times. The 
embryos were collected in separate microfuge tubes containing 30 µl of Lysis buffer II and 
incubated at 55°C in thermomixer for 3 hrs. After this digestion step, the samples were boiled 
in water bath for 10 min and centrifuged. The supernatant was transferred into a new tube and 
stored at -20°C. 
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2.2.1.5 Isolation of genomic DNA from preimplantation embryos 
 
Blastocysts were isolated from the uterus of superovulated female mice. Individual Blastocysts 
were collected in a PCR tube (0.2 ml) containing 5 µl Ampuwa H2O. Genomic DNA was 
extracted by freeze-thaw method. In brief, the samples were incubated on dry ice for 2 min 
and thawed by centrifugation at a full speed. This procedure was repeated 3 times. Finally, the 
tube content was collected by short centrifugation and stored at -20°C. 
 
2.2.1.6 Isolation of genomic DNA from cultured blastocysts 
 
DNA was prepared by incubating the cultured blastocysts with 15 µl of Lysis buffer III for 4 
hrs at 55°C followed by incubation at 90°C for 10 min. 
 
Lysis buffer III  50 mM Tris/HCl (pH 8.0) 
0.5 mM EDTA (pH 8.0) 
0.5% Tween 20 
0.2 mg/ml Proteinase K 
 
2.2.1.7 Isolation of total RNA from tissue samples and cultured cells 
 
Total RNA isolation (TRI) reagent is an improved version of the single-step method for total 
RNA isolation described first by Chomczynski and Sacchi (1987). The composition of the 
reagent includes phenol and guanidine thiocyanate in a monophase solution. In order to avoid 
any RNase activity, the homogeniser used for RNA isolation was previously treated with 
RNase away and DEPC water and RNase-free Eppendorf cups were used during the 
preparation. Tissue samples (50-100 mg each) were homogenised in 1 ml of TRI reagent by 
using a glass-teflon or plastic homogeniser. The homogenate was vortexed and incubated on 
ice for 15 min to permit the complete dissociation of nucleoprotein complexes. Then, 0.2 ml of 
chloroform was added to the sample, vortexed and incubated on ice for further 10 min. After 
centrifugation at 12000xg for 15 min at 4°C, the colourless upper aqueous phase was 
transferred into a new tube. After adding of 500 µl of isopropanol, solution was mixed and the 
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RNA was precipitated by centrifugation at 7500xg for 10 min. Finally, the pellet was washed 
with 75% ethanol and dissolved in 50-100 µl DEPC-H2O. The RNA was stored at -80°C. 
 
2.2.1.8 Determination of the nucleic acid concentration 
 
The concentration of nucleic acids was determined spectrophotometrically by measuring 
absorption of the samples at 260 nm. The quality of nucleic acids i.e. contamination with salt 
and protein was checked by measuring the absorbtion at 280 nm. The concentration was 
calculated according to the formula: 
C = (E 260 – E 280) fc 
C = concentration of sample (µg/µl) 
E 260 = ratio of extinction at 260 nm 
E 280 = ratio of extinction at 280 nm 
f = dilution factor 
c = concentration (standard) / absorption (standard) 
for double stranded DNA: c = 0.05 µg/µl 
for RNA: c = 0.04 µg/µl 
for single stranded DNA: c = 0.03 µg/µl 
 
2.2.2 Nucleic acid electrophoresis 
 
Gel electrophoresis is the technique by which mixture of charged macromolecules, especially 
nucleic acids and proteins are separated in an electrical field according to their mobility which 
is directly proportional to macromolecule’s charge to mass ratio. Agarose gels are used to 
electrophorese nucleic acid molecules from as small as 50 base pairs to more than 50 
kilobases, depending on the concentration of the agarose and the precise nature of the applied 
electrical field (constant or pulse). Usually, 1 g of agarose was added in 100 ml of 0.5x TBE 
buffer and boiled in the microwave to dissolve the agarose. The agarose solution was cooled to 
about 60°C before adding 3 µl ethidium bromide (10 mg/ml) and poured into a horizontal gel 
chamber. The 0.5x TBE buffer was used also as electrophoresis running buffer in the gel 
chamber. The DNA samples were mixed with 5x loading buffer and then loaded into the wells 
of the gel. The electrophoresis was carried out at a steady voltage (50-100 V). The size of the 
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DNA fragments on agarose gels was determined by extrapolating the size from a DNA size 
marker which was also loaded along with the samples in a separate lane of the gel. After 
electrophoresis, the DNA in the gel was photographed using a UV gel documentation system. 
 
2.2.3 Isolation of DNA fragments from agarose gel 
 
The Wizard® SV Gel and PCR Clean-Up System is designed to extract and purify DNA 
fragments of 100 bp to 10 kb from standard or low-melt agarose gels or to purify PCR 
products directly from a PCR amplification. PCR products are commonly purified to remove 
excess nucleotides and primers. The Wizard® SV Gel and PCR Clean-Up System is based on 
the ability of DNA to bind to silica membranes in the presence of chaotropic salts. After gel 
electrophoresis one volume of Membrane Binding Solution was added to the excised from 
agarose DNA fragment and incubated at 50°C for 10 min. In case of PCR products an equal 
volume of Membrane Binding Solution was added. After the gel slice was dissolved 
completely, it was transferred onto the minicolumn and incubated for 1 min. Thereafter the 
minicolumn was centrifuged at 16000xg for 1 min. The flow through was discarded and the 
column was washed two times with 700 µl and 500 µl of Membrane Wash Solution 
respectively. After empting of the collection tube the minicolumn was centrifuged one more 
time for 1 min to remove any residual ethanol and placed into a new 1.5 ml microcentrifuge 
tube. To elute DNA, 20 µl of H2O was applied directly to the centre of the column, incubated 
for 1 min and centrifuged for 1 min at 16000xg. 
 
Membrane Wash Solution  10 mM Potassium acetate (pH 5.0) 
80% Ethanol 
16.7 µM EDTA (pH 8.0) 
 
Membrane Binding Solution  4.5 M Guanidine isothiocyanate 
0.5 M Potassium acetate (pH 5.0) 
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2.2.4 Enzymatic modifications of DNA 
 
2.2.4.1 Digestion of DNA using restriction enzymes 
 
Restriction enzyme digestions were performed by incubating double-stranded DNA with an 
appropriate amount of restriction enzyme in its respective buffer as recommended by the 
supplier and incubated at the optimal temperature for that specific enzyme. Standard 
digestions include    2-10 U enzyme per microgram of DNA. Reactions were usually incubated 
for 1-3 hrs to ensure complete digestion at the optimal temperature for enzyme activity 
(typically 37°C). 
 
2.2.4.2 Dephosphorylation of 5' ends of DNA 
 
To prevent the recircularization of restriction digested plasmids without insertion of a DNA 
fragment, an alkaline phosphatase treatment is necessary. Alkaline phosphatase catalyses the 
hydrolysis of 5'-phosphate residues from DNA. The following components were mixed: 
  
1-5 µg vector DNA 
4 µl 10x Dephosphorilation buffer 
1 µl alkaline phosphatase (0.01 U) 
in a total volume of 40 µl 
 
The reaction was incubated at 37°C for 30 min, and the reaction was stopped by incubation at 
85°C for 15 min. Dephosphorylated DNA was purified by agarose gel electrophoresis and gel 
extraction. 
 
2.2.4.3 Ligation of DNA fragments 
 
The ligation of an insert DNA into a vector (digested with appropriate restriction enzyme) was 
carried out in the following reaction: 
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25-50 ng vector DNA (linearized) 
50-100 ng insert DNA 
1 µl 10x ligation buffer or 5 µl 2x ligation buffer 
0.3 µl T4 DNA ligase (5U/µl) 
in a total volume of 10 µl 
 
Blunt-end ligations were carried out at 16°C for overnight, whereas overhang-end ligations 
were carried out at 4°C overnight. 
 
2.2.4.4 TA - cloning 
(Clark, 1988; Hu, 1993) 
 
Taq polymerases have a terminal transferase activity that results in the template-independent 
addition of a single nucleotide to the 3' ends of PCR products. In the presence of all 4 dNTPs, 
dATP is preferentially added. This terminal transferase activity is the basis of the TA-cloning 
strategy. For cloning of PCR products pGEM-T Easy vector system that has 5' T overhangs 
was used. The reaction was carried out by mixing the following ingredients: 
 
50 ng of pGEM-T Easy Vector 
PCR product (1:3, vector to insert ratio) 
1 µl T4 DNA Ligase 10x buffer 
1 µl T4 DNA Ligase 
in a total volume of 10 µl 
 
The content was mixed by pipetting and the reaction was incubated overnight at 4°C. 
 
2.2.4.5 Non-radioactive dye terminator cycle sequencing 
 
Non-radioactive sequencing was performed with the Dye Terminator Cycle Sequencing-Kit 
(Amersham). The principle of this method is based upon chain termination reaction (Sanger et 
al. 1977). The reaction was carried out by adding the following components: 
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1 µg of plasmid DNA or 100-200 ng of purified PCR products 
10 pmol of primer 
3 µl ET-mix 
  in a total volume of 10 µl 
 
The ET-mix contains dNTPs, dideoxy dye terminators and Taq DNA polymerase. Elongation 
and chain termination take place during the following PCR reaction: 
 
95°C  4 min  
95°C 30 sec (denaturation) 
55°C 15 sec (annealing)  25 cycles 
60°C 4 min (elongation) 
 
2.2.5 Transformation of competent bacteria 
(Ausubel et al., 1994) 
 
Transformation of the bacteria was done by gently mixing one aliquot of competent bacterial 
cells (50 µl) with 10 µl of ligation reaction. After incubation for 20 min on ice, bacteria were 
heat shocked for 1 min at 37°C and quick chilled for 2 min on ice. Thereafter, 600 µl of 
S.O.C. medium was added to the bacteria and recovered by incubating at 37°C with shaking 
for 1 h. They were plated on LB-agar plates containing appropriate antibiotic, for blue-white 
selection additionally 1 mM IPTG and 40 mg/ml X-Gal were added. 
 
2.2.6 Polymerase Chain Reaction (PCR) 
 
The polymerase chain reaction (PCR) is one of the most important techniques in the field of 
molecular biology. It is a very sensitive and powerful technique (Saiki et al., 1988) that is 
widely used for the exponential amplification of specific DNA sequences in vitro by using 
sequence specific synthetic oligonucleotides (primers). The general principle of PCR starts 
from a pair of oligonucleotide primers that are designed so that a forward or sense primer 
directs the synthesis of DNA towards a reverse or antisense primer, and vice versa. During the 
PCR, the Taq DNA polymerase (a heat stable polymerase) (Chien et al., 1976) catalyses the 
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synthesis of a new DNA strand that is complementary to a template DNA from the 5' to 3' 
direction by a primer extension reaction, resulting in the production of the DNA region 
flanked by the two primers. It allows the rapid and unlimited amplification of specific nucleic 
acid sequence that may be present at very low concentration in any sample. 
 
2.2.6.1 PCR amplification of DNA fragments 
 
The amplification cycles were performed in an automatic thermocycler. The PCR reaction 
contains following components: 
 
1 µl DNA (20-50 ng) 
1 µl forward primer (10 pmol) 
1 µl reverse primer (10 pmol) 
1 µl 2 mM dNTPs 
2 µl 10x PCR buffer 
0.6 µl 50 mM MgCl2 
0.2 µl Taq DNA Polymerase (5U/µl)  
Up to 20 µl H2O 
 
The reaction mixture was placed in a 200 µl reaction tube and placed in thermocycler. A 
standard PCR program is shown here: 
 
Initial denaturation 95°C  5 min 
Elongation  95°C  30 sec   (denaturation) 
55° - 65°C 30-45 sec  (annealing)  35 cycles 
72°C  1-2 min  (extension) 
Final extension 72°C  10 min 
 
2.2.6.2 Genotyping PCR 
 
For genotyping of Sall1 and Sall4 mouse lines three different primers were designed in such a 
way that amplification product of wild type and mutant allele had different length. Sall1 
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genotyping was performed with pTKneoF264, Ex2F264, SAR364 primers. Sall4 genotyping 
was performed with S4MI1R1a, pGeoR6, S4I1F1. The genotyping was performed in 
following reaction: 
1 µl DNA  
1 µl primer 1 (10 pmol) 
1 µl primer 2 (10 pmol) 
1 µl primer 3 (10 pmol) 
1 µl 2 mM dNTPs 
2 µl 10x PCR buffer 
0.6 µl 50 mM MgCl2 
0.2 µl Taq DNA Polymerase (5U/µl)  
Up to 20 µl H2O 
 
PCR program was used for Sall1 genotyping: 
 
Initial denaturation 95°C  5 min 
Elongation  95°C  30 sec 
64°C  30 sec    35 cycles 
72°C  1 min 30 sec 
Final extension 72°C  10 min 
 
PCR program was used for Sall4 genotyping: 
 
Initial denaturation 95°C  5 min 
Elongation  95°C  30 sec 
64°C  30 sec   35 cycles 
72°C  50 sec 
Final extension 72°C  10 min 
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2.2.6.3 Reverse transcription PCR (RT-PCR) 
 
RT-PCR is a technique, which generates cDNA fragments from the RNA templates and 
thereafter amplifies it by PCR. It can be used to determine the tissue specific expression of 
genes or expression of a gene in different development stages. 1-5 µg of total RNA was mixed 
with 1 µl of oligo (dT)18 primer (10 pmol/µl) and RNase free H2O to a total volume of 12 µl. 
To disrupt the secondary structure of the RNA, which might interfere with the cDNA 
synthesis, the mixture was heated to 70°C for 10 min, and then quickly chilled in ice. After a 
brief centrifugation, the following components were added to the reaction mixture: 
 
4 µl 5x First strand buffer 
2 µl 0.1 M DTT 
1 µl 10 mM dNTPs 
 
The reaction was mixed and incubated at 42°C for 2 min. Then, 1 µl of reverse transcriptase 
enzyme (SuperScript II) was added and further incubated at 42°C for 50 min for the first 
strand cDNA synthesis. The reaction was inactivated by heating at 70°C for 15 min. 1 µl of 
the first strand reaction was used for the PCR reaction (as described above). 
 
2.2.7 Real time RT-PCR using SYBR Green I dye 
 
SYBR Green I dye intercalates into double-stranded DNA and produces a fluorescent signal. 
The intensity of the signal is proportional to the amount of dsDNA present in the reaction. 
Therefore, in each step of the PCR reaction, the signal intensity increases as the amount of 
product increases. Thus it provides a very simple and reliable method to monitor the PCR 
reactions in a real time course. Another advantage of this technique is that no modification in 
oligonucleotide primers are required which facilitates primer design/synthesis and more 
important it lowers the running cost of PCR reaction. However, optimization of the reaction 
conditions for each primer set is required. The expression of genes of interest was quantitated 
using ABI Prism Real-Time detection system 7900 (Applied Biosystems) by using 2x 
QuantiTest SYBR Green PCR Master Mix (Qiagen). Briefly, according to manufactures 
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instructions the Master mix for reactions was prepared by combining the following items on 
ice in a 0.5 ml microcentrifuge tube: 
 
5 µl 2x SYBR Green Mix 
2.5 µl Primer mix (forward and reverse, 1 pmol/µl) 
2.5 µl cDNA template 
 
cDNA templates were synthesized from 1-2 µg of total RNA from E8.5 embryo using 
oligo(dT)18 primer and SuperScript II reverse transcriptase. The cDNA for standard curves 
was prepared in serial dilutions: 1; 0.4; 0.16; 0.064. All samples were amplified in duplicates. 
The program for ABI Prism was created according to the user manual and consists of the 
following steps: 
 
1) Initial PCR activation step:  95 °C 15 min  
 
2) Amplification   94 °C 30 sec 
63 °C  30 sec   45 cycles 
     72 °C 30 sec   
 
3) Dissociation step   95 °C 15 sec 
60 °C  15 sec (ramping rate 2%)  
95 °C 15 sec 
 
Data analysis was done by SDS 2.1 software using standard curve method and Microsoft 
Office Excel. To verify the specificity and efficiency of real-time analysis, the PCR products 
were analyzed by monitoring their dissociation curves. The expression of the investigated 
genes was normalized to ß-actin mRNA expression. 
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2.2.8 Protein biochemical methods 
 
2.2.8.1 Isolation of total protein 
 
Proteins were extracted from fresh or frozen mouse tissues by homogenization in tissue lysis 
buffer containing protease inhibitors. 
 
Protein lysis buffer   50 mM Tris/HCl (pH 7.5) 
150 mM NaCl 
1 mM DTT 
1% Nonidet P-40  
2.5 mM EDTA 
10 µg/ml Aprotinin 
10 µg/ml Leupeptin 
 
Lysates were sonicated on ice and centrifuged at 16000xg for 20 min at 4°C. Supernatant, 
containing membrane, organelles and cytosol proteins was collected and stored at -800C, or 
used immediately for Western blotting. 
 
2.2.8.2 Electrophoresis of proteins 
 
The NuPAGE® Pre-Cast Gel System (Invitrogen) is a polyacrylamide gel system for high 
performance gel electrophoresis and is based on SDS-PAGE gel chemistry (Laemmli, 1970). 
It consists of NuPAGE® Bis-Tris Pre-Cast Gels and specially optimized buffers which have 
an operating pH of 7.0, giving the system advantages over existing polyacrylamide gel 
systems with an operating pH of 8.0. The neutral pH increases the stability of the proteins and 
provides better electrophoretic results. To 10 µl of whole protein lysate 10 µl of 2x Protein 
sample buffer was added. The samples were denatured by boiling in the water bath for 10 min, 
cooled at RT for 5 min and loaded in SDS-PAGE (NuPage 4-12% Bis-Tris gel). The gel 
electrophoresis was run in 1x SDS MES buffer (Invitrogen). To determine the molecular 
weight of the proteins on the gel, 10µl of a pre-stained molecular weight standard (See Blue 
Plus2, Invitrogen) was also loaded. The gel was run at 100 V for 2 hrs at RT. 
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2.2.8.3 Transfer of protein onto nitrocellulose membranes 
(Gershoni and Palade, 1982) 
 
After the electrophoresis of proteins in SDS-PAGE, proteins were transferred onto a 
nitrocellulose membrane by semi-dry system using an electro-blotter (Biometra). Eight pieces 
of GB004 Whatman filter paper were cut similar to the size of the gel. First, four papers 
soaked with transfer solution were placed on semi dry transfer machine’s lower plate and then 
equilibrated nitrocellulose membrane was placed over them. Next the gel was placed avoiding 
any air bubbles. Another four Whatman paper soaked with transfer solution were placed over 
to complete the sandwich model. The upper plate was placed over this sandwich and the 
protein transfer was carried out at 10 W (150 – 250 mA, 39 V) for 1 h. 
 
10x Transfer buffer   250 mM Tris 
     1.5 M Glycine 
 
Transfer solution   1x Transfer buffer 
     10% Methanol 
 
2.2.8.4 Staining of polyacrylamide gels 
 
To assess transfer efficiency of proteins onto nitrocellulose membranes, the gel was incubated 
overnight in Coomassie blue staining solution. The methanol and acetic acid in the staining 
solution cause the proteins to precipitate and thus be fixed in the gels. In acidic solution 
Coomassie Blue dye interacts chiefly with arginine residues of the proteins, resulting in colour 
development in the gel. Gel was destained in Coomassie destaining solution for 2-3 hrs at RT. 
 
2.2.8.5 Western blotting 
 
The membrane was first incubated in P1 buffer with 5% milk powder for 1 h at RT in order to 
block non-specific binding sites. Membrane was then incubated with a primary antibody at the 
recommended antibody dilution in P2 (P1 buffer with 2% milk powder) overnight at 4°C. The 
unbound antibody was removed by washing three times in P2 for 20 min. Thereafter the 
 39
Materials and Methods 
____________________________________________________________________________  
immunoblot was incubated with the alkaline phosphatase conjugated secondary antibody at 
1:10000 dilution in P2 for 1 h at RT. Again non-specific bound antibody was washed 3 times 
in P2 and than immunoblot was equilibrated with AP buffer for 5 min at RT. Finally, alkaline 
phosphatase activity was detected by incubation in 10 ml of staining solution and the coloring 
reaction was stopped by washing in H2O. 
 
P1 buffer:   150 mM NaCl  
100 mM Tris/HCl (pH 7.5) 
0.1% Tween-20 
 
AP buffer   100 mM Tris/HCl (pH 8.5) 
100 mM NaCl 
5 mM MgCl2 
 
Staining Solution:  66 µl NBT 
33 µl BCIP 
in 5 ml of AP buffer 
 
2.2.8.6 Generation of polyclonal antibody 
 
2.2.8.6.1 Sequence analysis of Sall4 protein 
 
Different computational tools were applied to select potential antigenic domains. The primary 
amino acid sequence of the Sall4 protein (GenBank NP_780512) was obtained from the NCBI 
database (http://www.ncbi.nlm.nih.gov). In order to select unique sequences for antibody 
generation, the Sall4 peptide sequence was compared with peptide sequences of the other 
members of the SALL gene family using the Multalin programme 
(http://prodes.toulouse.inra.fr/multalin/multalin.html). Before synthesis of the fusion protein, a 
hydrophobicity profile analysis using the Kyte and Doolittle scale and polarity analysis by 
Gratham scale was carried out (http://us.expasy.org/tools/protscale.html). A unique sequence 
from the C-terminus of Sall4 was selected to synthesize a fusion protein. 
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Fragment for fusion protein 
Sall4 
 
Figure 2.1. Schematic representation of Sall4 protein and C-terminus part of the protein with was used for the 
fusion protein generation (red). 
 
2.2.8.6.2 Amplification and cloning of Sall4 fusion construct 
 
Sall4 cDNA C-terminal domain (1080 bp) was amplified using primers with 5' overhangs 
restriction sites sequences (dom1F1 and dom1R1). PCR was performed using PfuI DNA 
polymerase (Promega) with proof-reading activity to avoid mismatches in amplification. 
Touch-down PCR conditions were as follows: 
 
95 °C  4 min 
95°C  30 sec 
62°C-56°C 45 sec  7 cycles 
72°C  2 min 
 
95°C  30 sec 
56°C  45 sec  30 cycles 
72°C  2 min 
72°C  10 min 
 
PCR products were digested with EcoRI and XhoI enzymes, purified from a 1% agarose gel 
and ligated into pET41a expression vector and constructs were transformed into competent 
E.coli DH5α cells. 
 
2.2.8.6.3 Expression of recombinant proteins in the pET vector 
 
The recombinant pET41a construct was transformed into the host bacterial strain E.coli BL-21 
(DE3). The BL-21 strain (Novagen) is lysogenic for a prophage that contains an IPTG 
1 2 3 4 
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inducible T7 RNA polymerase. A single colony was picked from a freshly streaked plate into 
50 ml of LB culture medium containing kanamycin for overnight culture at 37°C. Next day 
overnight culture was diluted into 500 ml fresh LB medium and cultured further at 37°C until 
OD600 reached 0.6-0.8. A non-induced sample was collected as a control. Induction was 
performed by adding IPTG to a final concentration of 1 mM and cultured for 4 hrs. Finally, 
the bacterial cells were harvested by centrifugation at 5000xg for 10 min at 4°C and frozen at -
80°C. 
 
2.2.8.6.4 Purification of GST fusion proteins 
 
The pellet of bacterial cells was resuspended in 10 ml of Lysis buffer (pH 8.0) and sonicated 
on ice. The cell debris from protein extract were removed by centrifugation for 20 min at 
10000xg at 4°C. The supernatant was filtrated through 0.45 µm filter and incubated with pre-
equilibrated Glutathione-agarose (Sigma) for 1 h at 4°C with gentle mixing. The bound resin 
was washed four times with PBT at 4°C. Thereafter fusion protein was eluted with 3 ml 
Elution buffer (10mM reduced glutathione in 50 mM Tris/HCl, pH 7.5) and eluate was 
collected into three fractions. Purified protein was dialysed overnight at 4°C against PBS. 
Protein quality and quantity were checked by SDS-PAGE and Western blotting. 
 
2.2.8.6.5 Immunisation of rabbits 
 
Two rabbits were immunised each with 500 µg of Sall4 fusion protein mixed with Freund’s 
complete adjuvant in 1:1 ratio. Before injection, preimmune sera were collected from the 
animals. First booster immunisation was performed after 14 days after first injection with 1:1 
ratio of antigen with Freund’s incomplete adjuvant. Second booster was given after 28 days 
and a third booster after 56 days from the first immunisation. Final bleeding was done after 86 
days from first immunisation. The antiserum was aliquoted and stored at -800C. 
 
2.2.8.6.6 Affinity purification of polyclonal antibody 
 
For affinity purification, HiTrap NHS-activated 1 ml columns (Amersham) were used, the 
columns are made of medical grade polypropylene, which is biocompatible and non-
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interactive with biomolecules. NHS-Activated Sepharose is designed for the covalent coupling 
of ligands containing primary amino group. Non-specific adsorption of proteins to HiTrap 
columns is negligible due to the hydrophilic properties of the base matrix. The activated gel is 
supplied in 100% isopropanol to preserve the stability of the activated gel prior to coupling. 
 
2.2.8.6.6.1 Ligand coupling 
 
Coupling buffer:  0.2 M NaHCO3 
0.5 M NaCl (pH 8.3) 
 
Sall4-GST fusion protein (1 mg) was dialysed overnight against Coupling buffer. Isopropanol 
present in column was washed with 1 M HCl (ice cold). The flow rate during the pumping was 
adjusted to about 1 ml/min. Immediately after washing, 1 ml of the ligand solution was 
injected onto the column, then column was sealed and let it stand for 4 hrs at 4°C. 
 
2.2.8.6.6.2 Washing and deactivation 
 
Buffer A: 0.5 M Ethanolamine, 0.5 M NaCl (pH 8.3) 
Buffer B: 0.1 M Acetate, 0.5 M NaCl (pH 4.0) 
 
A series of alternate washing (injection 3x2 ml) with buffer A and buffer B was done. Finally, 
two ml of PBS was injected. 
 
2.2.8.6.6.3 Affinity purification of antiserum 
 
The column was equilibrated with 10 column volumes of start buffer (PBS). The antiserum 
was diluted two times with PBS and filtered through a 0.45 µm filter and then applied onto the 
column. During pumping, a constant flow rate of 0.5 ml/min was maintained. The column was 
washed with 10 column volumes of PBS. Elution was done with three volumes of 100 mM 
glycin/HCl (pH 2.7). The purified antibody fraction was desalted by dialysis against PBS. The 
column was re-equilibrated with 10 volumes of PBS. The antiserum solution was recovered 
from the dialysis tubing and concentrated using Centrisart columns to about 0.5 ml. 
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2.2.8.6.7 Protein G purification of antibody 
 
Protein G sepharose beads (Santa Cruz) were equilibrated by washing five times in binding 
buffer (20 mM sodium phosphate buffer, pH 7.0, 0.15 M NaCl). Antiserum diluted in ratio 1:1 
with binding buffer was mixed with protein G sepharose and incubated at RT for 1.5 h. After 
brief centrifugation step, the supernatant was removed and protein G was washed four times 
with binding buffer. Elution was done with four protein G volumes of Elution buffer (100 mM 
glycin/HCl, pH 2.7). Eluted antibody fractions were neutralized by adding 3.5 µl of 1 M 
Tris/HCl (pH 7.5). Finally, antibody was dialyzed overnight against PBS. 
 
2.2.9 Eukaryotic cell culture methods 
 
2.2.9.1 Cell culture conditions 
 
NIH3T3 cells and F9 cells were grown in DMEM medium containing 10% fetal bovine serum 
and 1% penicillin/streptomycin solution. The cells were cultured at 37°C in a humidified 
incubator with 5% CO2. 
 
2.2.9.2 Trypsinisation of eukaryotic cells 
 
Cells were washed twice with sterile PBS and incubated in minimal amount trypsin-EDTA 
(0.5 g/l trypsin, 0.2 g/l EDTA) at 37°C until they had detached from the dish. The process was 
controlled under an inverted microscope. Trypsin was inhibited by addition of growth medium 
in which the cells were subsequently resuspended. The trypsin was removed by centrifugation 
at 2000xg for 3 min. Cells were resuspended in an appropriate volume of cell culture medium 
and transferred into a new flask with medium. 
 
2.2.9.3 Cryopreservation and thawing of eukaryotic cells 
 
Trypsinased cells were spun down (1000xg for 5 min) in 4 ml of growth medium. The 
supernatant was aspirated and the cells were resuspended in ice-cold freezing medium 
(DMEM, 20% FCS, 10% DMSO). The aliquots of the cells were kept for 2 days at -80°C and 
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then stored in liquid nitrogen. For revitalization, frozen cells were quickly thawed and cells 
were inoculated in a suitable amount of growth medium. 
 
2.2.9.4 Transient transfection of the cells 
 
Approximately 4 x 105 fibroblast cells (NIH3T3) were plated on a cell culture slide (Falcon) 
and cultured overnight in 1 ml of DMEM medium containing 10% FCS and 
penicillin/streptomycin at 37°C and 5% CO2. The construct DNA (2 µg of pcDNA3.1-Sall1tr) 
was diluted in 100 µl of Opti-MEM medium. Lipofectamine 2000 was diluted in 100 µl of 
Opti-MEM medium in ratio 1:3 per µg of DNA. After 10 min of incubation, the diluted DNA 
was mixed with diluted Lipofectamine 2000 and incubated for 30 min at RT to allow DNA 
complex formation. Meanwhile the cells were washed twice with PBS. After DNA complex 
formation 800 µl of cell medium was added to the reaction tube, mixed vigorously and applied 
to the cells in culture slide, The transfection was carried out by incubating the cells at 37°C for 
3 hrs in a CO2 incubator, than 1 ml of Opti-MEM medium containing 20% FBS was added 
and further incubated for 2.5 hrs. Finally, cells were washed with PBS and supplemented with 
2 ml of fresh complete growth medium. Cells were incubated for 24-48 hrs at 37°C and 5% 
CO2. 
 
2.2.9.5 Immunocytochemical analysis 
 
Transiently transfected cells attached to the cell culture slide were rinsed twice with PBS and 
fixed with 4% PFA in PBS for 30 min at RT, then rinsed again with PBS. Fixed cells were 
permeabilized and blocked with GSDB for 1 hr. For the immunodetection cells were incubated 
with primary antibody at the recommended dilution in GSDB antibody solution overnight at 
4°C.  The unbound primary antibody was removed by washing three times in PBT for 10 min. 
Thereafter the cells were incubated with either FITC or Cy3-coupled secondary antibody at 
1:200 dilution in GSDB antibody solution for 1.5 hrs at RT. The cells were washed three times 
in PBT. After washing, the cells were mounted with Vectashild mounting medium containing 
DAPI and were visualised with fluorescence microscope (BX-60, Olympus). 
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2.2.10 Histological techniques 
 
2.2.10.1 Tissue preparation for paraffin-embedding 
 
The freshly prepared tissue was fixed for 24-72 hrs in 4% PFA to cross link free amino groups 
of proteins and to prevent the alterations in the cellular structure. The dehydration process was 
accomplished by passing the tissue through a series of increasing alcohol concentrations. For 
this purpose, the tissue was serially incubated in 70%, 80%, 90%, 96% and 100% ethanol for 
30 min at RT each step. The ethanol was replaced from the tissue by incubating in isopropanol 
for overnight. Tissue was then serially incubated in different compositions of 
isopropanol/xylene in ratios 3:1, 1:1 and 1:3 for 30 min-1 h at RT each step. Then tissue was 
incubated in 100% xylol overnight. Then the tissue was incubated in paraplast at 60°C 
overnight and next day the paraplast was changed at least three times. Finally, the tissue was 
placed in embedding mould and melted paraffin was poured into the mould to form a block. 
The block was allowed to cool and then stored at 4°C. 
 
2.2.10.2 Sections of the paraffin block 
 
The paraffin blocks were first cut to the optimal size before clamping them into the microtome 
(Hn 40 Ing.). The cut-thickness used for paraffin embedded sections was 3-7 µm. The sections 
were floated on 42°C water bath to allow complete spreading and subsequently collected onto 
Superfrost slides. A fine brush was used to transfer the sections to slides. Slides were then 
dried at 40°C, to remove the excess of water. The sectioned slides were then stored at RT for 
further analysis. 
 
2.2.10.3 Staining of the histological sections (Hematoxylin-Eosin staining) 
 
The sectioned slides were first incubated three times in xylene for 3 min each, followed by 
incubation in 100%, 96%, 80%, 70% and 50% ethanol for 2 min each. Thereafter slides were 
washed for 5 min in H2O and stained for 3 min in hematoxylin. This staining was followed by 
washing in running tap water for 10 min. The treated slides were destained in acid ethanol (1% 
acetic acid, 70% ethanol) for 1 min, washed in H2O for 2 min and stained with eosin (0.1% + 
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2% acetic acid) for 1 min, then in H2O for 1 min and incubated in 50%, 70%, 80%, 90%, 96% 
and 100% ethanol for 2 min in each. Finally the stained slides were incubated two times in 
xylene for 3 min and mounted with cover slides. 
 
2.2.10.4 Immunohistochemistry 
 
Fixation and subsequent treatment of mouse tissue was performed as described above. Tissue 
sections (5-7 µm) were deparaffinized 3 times with xylene and rehydrated by 50%, 70%, 80%, 
90%, 96% and 100% ethanol for 2 min in each. For immunostaining, sections were washed 3 
times in PBS and were then incubated in GSDB blocking solution for 1 h at RT. After 
blocking, the tissue sections were incubated with primary antibody (1:50-1:200) overnight at 
4°C in humidified chamber. Next day, the sections were rinsed three times in PBS and 
incubated with secondary antibody (e.g. FITC-conjugated or Cy3-conjugated, 1:200) for 1 h at 
RT. After incubation with secondary antibody, sections were washed again in PBS for three 
times 10 min each. The slides were air-dried and mounted with DAPI to stain the nuclei. The 
immunostained sections were examined using a fluorescence-equipped microscope (BX60, 
Olympus). 
 
2.2.11 Techniques for recovery and culture of preimplantation embryos 
 
2.2.11.1 Superovulation 
 
Adult female mice were superovulated by intraperitoneal injections of 5 IU of pregnant mare’s 
serum gonadotropin (PMSG, Sigma). After 44-48 hrs the females were injected by 5 IU of 
human chorionic gonadotrophin (HCG; Sigma) and bred with males. Next morning the 
females were checked for vaginal plug (VP). The E0.5 was considered to be 12:00 noon at the 
day of vaginal plug. 
 
2.2.11.2 Preparation of blastocyst stage embryos 
 
The VP positive female mice at E3.5 stage were killed by cervical dislocation. The skin and 
peritoneum were opened with the large transverse incision to expose the abdominal cavity. 
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The oviducts with the upper part of the uterus were dissected and placed into a drop of M16 
medium. Blastocyst stage embryos were flushed from the uterus of superovulated females. 
Under dissection microscope a needle attached to a 1 ml syringe was inserted in the fimbrial 
end of the oviduct. The needle was then held with forceps and oviducts were flashed with 0.05 
ml of M16 medium. Embryos were collected with a pipette and washed several times with 
M16 medium. The collected embryos were washed two times in a drop of PBS and each single 
embryo was transferred into a PCR cup (0.2 ml) containing 5 µl H2O. The single isolated 
blastocysts were used for genotyping. 
 
2.2.11.3 In vitro culture of blastocyst stage embryos 
 
The blastocysts were flushed out from the uterus of plugged females at day 3.5 (as described 
at 2.2.11.2) and placed in gelatinized 96-well plate. Embryos were cultured at 37°C and 5% 
CO2 in ES cell medium. Embryonic stem cell growth was monitored daily under inverted 
microscope for 5 days. 
 
2.2.12 Whole mount in situ hybridisation 
(Wilkinson, 1992; modified) 
 
Whole mount in situ hybridisation method was employed in order to determine the expression 
pattern of genes during embryogenesis. The principle behind in situ hybridisation is that a 
specific labelled antisense mRNA probe binds to complementary mRNA sequences in the 
fixed tissue, which can be detected by enzymatic colouring reaction. 
 
2.2.12.1 Embryo dissection 
 
After breeding, the E7.5 and E8.5 stage pregnant female mice were dissected and the embryos 
were isolated and placed in the ice-cold PBS. Embryos were than fixed overnight at 4°C in 4% 
PFA in PBS. The embryos were washed twice in ice-cold PBT for 10 min and than dehydrated 
by incubating for 5 min in 25%, 50%, 75%, 2x100% methanol in PBT, respectively. Embryos 
can be stored at this point for several months in -20°C. 
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The probes for Pax3 and brachyury genes (with the permission of Prof. Herrmann, Berlin) 
were kindly provided by Max-Plank Institute of Biophysical Chemistry Plasmid Library. 
 
 sense 
polymerase 
antisense 
polymerase 
sense 
restriction 
antisense 
restriction 
length of the 
probe 
Pax3  T7 PstI HindIII 519 bp 
Brachyury  T3  NotI 1 kb 
 
An aliquot of the linearised plasmids was tested on agarose gels, and the plasmid DNA was 
precipitated. The transcription was carried out as described: 
 
2 µl 10x transcription buffer 
1 µg linearised plasmid 
2 µl 0.2 M DTT 
2 µl dNTP labelling mix 
0.5 RNAase inhibitor (100 U/µl) 
2 µl RNA polymerase 
in 20 µl H2O 
 
Incubation was performed overnight at 37°C. Precipitation of the product was done as follows: 
 
20µl transcription reaction 
80 µl H2O 
1 µl glycogen (20µg/µl) 
35 µl ammonium acetate (10 M) 
250 µl ethanol (cold) 
 
The mixture was incubated for 15 min on dry ice, centrifuged for 10 min and washed with 500 
µl of 70% ethanol. The dried pellet was dissolved in 80 µl DEPC-H2O and stored at -20°C. 3-
4 µl of DIG-labeled probe was used per ml of hybridisation mix as described below. 
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2.2.12.2 Pre-hybridisation treatment and hybridisation of the embryos 
 
Rehydratation of embryos was performed by incubating the embryos for 5 min in 100%, 75%, 
50% methanol in PBT. They were washed twice in PBT and bleached with 6% hydrogen 
peroxide in PBT for 1 hr. This treatment decreased non-specific background (Wilkinson, 
1992). The embryos were then washed three times with PBT and treated with 10 µg/ml 
Proteinase K in PBT for 2 min (E7.5 and E8.5). The reaction was immediately stopped by 
adding 2mg/ml glycine in PBT, and then the embryos were washed three times for 5 min in 
PBT. The embryos were postfixed in 4% paraformaldehyde/0.2% glutardialdehyde in PBT for 
20 min and then washed twice in PBT. The hybridisation steps were carried out in 6 well cell 
culture dishes, and solutions were exchanged using a fine titration pipette. Prehybridisation 
was carried out by incubating in prehybridisation mix (PreHyb: 50% deionised formamide, 5x 
SSC, pH4.5, 1x Denhardt´s Solution, 100 µg/ml yeast tRNA, 1 mg/ml salmon sperm DNA) 
overnight at 70°C. Hybridisation solution (50% deionised formamide, 5x SSC, pH4.5, 100 
µg/ml yeast tRNA, 1 mg/ml salmon sperm DNA, 50 µg/ml heparin) and DIG-labeled RNA 
probe were mixed, denaturated at 80°C for 5 min. Hybridisation was carried out overnight at 
70°C in a humidified chamber. 
 
2.2.12.3 Detection of hybridisation signals 
 
Posthybridisation washes were performed to remove non-specifically bound probe. Washing 
was done two times for 30 min with Solution I (50% formamide, 5x SSC, 1% SDS) and two 
times for 45 min with Solution II (50% formamide, 2x SSC, 0.2% SDS). The embryos were 
than incubated for 5 min in freshly prepared MAB buffer (100 mM maleic acid, 150 mM 
NaCl, pH 7.5). Antibody blocking solution (2% blocking reagent in MAB, 10% sheep serum) 
was added to the embryos and incubated for 2-3 hrs at RT. Anti-DIG alkaline phosphatase 
conjugate antibodies were used for immunodetection of DIG-labeled probe. The embryos were 
incubated in blocking solution with 1% sheep serum overnight at 4°C with shaking. Post 
antibody washes were carried out in MAB buffer every hour during day at RT and overnight at 
4°. 
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2.2.12.4 Colour development and storage of the embryos 
 
NTMT solution (100 mM Tris-HCl, pH9.5, 50 mM MgCl2, 100 mM NaCl, 0.1% Tween-20) 
was used to wash embryos three times for 10 min. In order to detect alkaline phosphatase 
activity of the anti-DIG antibody, embryos were incubated in staining solution I (4.5 µl NBT, 
3.5 µl BCIP per ml NTMT) or in staining solution II (7.5 µl INT/BCIP per ml NTMT) at RT 
in the dark place. Staining level was monitored after 1-2 hrs by microscope. When the desired 
level of staining was achieved, the reaction was stopped by washing twice in PBT. The 
embryos were postfixed in 4% PFA overnight at 4°C and stored in PBT at 4°C. 
 
2.2.13 X-gal staining 
 
2.2.13.1 LacZ staining of mouse embryos 
 
LacZ is one of the most frequently used reporter gene in gene trap vectors. X-gal staining 
allows visualizing histochemically ß-galactosidase expression and studying the level of 
specific expression of gene disrupted by gene trap vector integration.  
Mouse embryos were dissected and washed twice in cold PBS. Then embryos were fixed for 4 
hrs at 4°C in solution B. Next, the embryos were washed three times for 5 min at RT in 
solution C. Then the solution C was replaced by solution D and embryos were incubated 
overnight at RT. Next day they were washed two times for 1 h in solution C and fixed again in 
4% PFA for 2 hrs at 4°C and stored in 70% ethanol at 4°C. 
 
Solution A    100 mM potassium phosphate buffer pH 7.4 
 
Solution B    4% PFA 
(fixing buffer)    5 mM EGTA 
     2 mM MgCl2
     in solution A 
 
Solution C    0.01% Na desoxycholate 
(washing buffer)   0.02% Nonidet P40 
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     5 mM EGTA 
     2 mM MgCl2
     in solution A 
 
Solution D    0.5 mg/ml X-gal 
(staining solution)   10 mM K3[Fe(CN)6] 
     10 mM K4[Fe(CN)6] 
     in solution C 
 
2.2.13.2 X-gal staining of blastocyst stage embryos 
 
The blastocyst stage embryos were rinsed twice with PBS (pH 7.4) and then fixed for 10 min 
at 4°C with 0.25% glutaraldehyde in PBS. After two times washing in PBS, the embryos were 
incubated in staining solution. Incubation was carried out in humidified chamber overnight in 
the dark at 37°C. Stained embryos were washed two times in PBS then placed over a glass 
slide under the mineral oil. The embryos on slide were observed under light microscope 
(BLX12, Olimpus). 
Staining solution   0.04% X-gal 
     1 mM MgCl2
10 mM K3[Fe(CN)6] 
10 mM K4[Fe(CN)6] 
in PBS (pH 7.4) 
 
2.2.14 BrdU staining 
 
Bromodeoxyuridine (BrdU), an analog of thymidine, is a uridine derivative that can be 
incorporated specifically into DNA in place of thymidine. Those cells that are synthesizing 
DNA (in S-phase of the cell cycle) will incorporate BrdU into the DNA. Cells, which have 
incorporated BrdU into DNA, can be quickly detected using an antibody against BrdU. The 
binding of the antibody is achieved by denaturation of the DNA. This is usually achieved by 
exposing the cells to acid or heat.  
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Pregnant mouse females were injected with 100 µg/g body weigh of mouse BrdU dissolved in 
0.9% NaCl. To detect BrdU incorporation, the mouse embryos were dissected after 2 hrs and 
washed twice in cold PBS. After that, embryos were fixed in 4% PFA overnight, then paraffin 
embedded, sectioned and mounted onto slides. To decrease antigen masking by chromatin 
proteins, the sections were digested in 1mg/ml trypsin in PBS for 10 min and then washed 3 
times in PBS. Denaturation of the DNA was carried out with 2.5 N HCl at 37°C for 15 min; 
slides were washed two times in PBS. Blocking was performed with 2% horse serum in PBS. 
Primary antibody rat anti-BrdU was incubated for 1 h (1:200 dilution) with following washing 
and incubation with secondary antibody (horse anti-rat IgG HRP-conjugated, 1:500 dilutions). 
After washing with PBS 100 µL of DAB substrate was added onto each slide and incubated 
for 15 min in the darkness. Slides were counterstained and mounted with HistoKit. 
 
2.2.15 Computer analysis 
 
For the analysis of the nucleotide sequences, programs like BLAST, BLAST2, MEGABLAST 
and other programs from National Centre for Biotechnology Information (NCBI) were used 
(www.ncbi.nlm.nih.gov). For restriction analysis of DNA sequence NEBcutter V2.0 
programme was used (http://tools.neb.com/NEBcutter2/index.php). Information about mouse 
alleles, phenotypes and strains was obtained from Jackson Laboratory 
(www.informatics.jax.org). For proteins studies ExPASy tools (www.expasy.ch) were used. 
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3. RESULTS 
 
3.1 Gene trap cell line 
 
3.1.1 Identification of Sall4 gene trap cell line 
 
In order to establish an appropriate mouse model system for Okihiro syndrome and to study 
the function of Sall4 gene we have searched for the Sall4 gene trap ES cell line clone in the 
database of German Gene Trap Consortium (GGTC) (Kohlhase, 2002c). The GGTC has 
established a resource of mutant ES cell lines, which have been obtained by random 
integration of the gene trap vector (Hansen et al., 2003). Partial sequencing results from 5’ 
RACE PCR of trapped exon sequences are available in the database at www.genetrap.de. 
We have identified the ES cell line W097E01 in the GGTC database and used it for further 
analysis, because 5’ RACE PCR result showed that the gene trap vector pT1ßgeo was spliced 
to exon 1 of the Sall4 gene (Fig 3.1). This ES cell line was used for blastocyst injection and 
generation of chimeric mice. 
  1 AGCCGCTAGTCCTCTTAGTTAGGGGTCTTCTTCCTTGGTTTTCGGGACCT 
  51 GGGACCGTGTTCCTCCGCCGACAGCGCACTAAGCTGAGTTAGAAACTCTG 
  101 GAGCTGCTGAGGCTGCTCTCCCTAGAGCCTGCTCCCAGTGGATGGGATGG 
  151 GGCTTCGCCTGCTTGCGCCTCGACATGGTGCGCGCATTGGGGCGCCGGGA 
  201 AGAGCCCTGGTGACTTGCCCCCTCTCCGCCACCAATTCCTGGAGGTGGGA 
  251 AATTTTAGCCCCCTTCGGCCGAAACGCGCATGGCCCAGTAATTCTCCCCC 
  301 TCAATAATGCATTGGGATTTATCATGAGCTGTGACAGATGGGTAACGACA 
  351 CCCCCCCCCCCCGGGGCGGAAAGATGCCAAGGCAAACAAAGGGGAAAAAC 
  401 GGGAACGGGAAGGAGAAGGGGGGGGGGGGGGAGGGGGGGGGGGAGGGGGG 
  451 GGGGGGAGGGGGCAAGGNCAGCCNCGGGGGGCAGGGCNCAGGGGTCGGGG 
  501 GAGGGGGGGGGAGGGGANNCGCCAGGGGGGCAAGGGGGGTGTNTTNTACA 
  551 AGCTCGGGCCCAAGACAGTGGAGGGCGCGGGGGGAGGGAAAGGGGGAAAG 
  601 GGGGGGAAGAGGGTGGGGCAGAAGGGGGGAGGCCGGGGACTAGAGGGGGC 
  651 AGAGGGAAGGGACTGGGGACCAGGGGGGGGAGAGGGGGGGGCAAGGGGAA 
  701 AAGAAAAGAGGGGGGGGGAAGGGGGGGGGGGGCGGGGGGGGGAACGGGGG 
  751 GGCGGGGGGACGGGGACGGGGGGCACAGGGGGAGGACGACGGGGGGACGG 
  801 GGGGGGGGGCAGCGGGGACAGGGAAAGGGGCAGGGGGACAGGGGGAACGG 
  851 GGGGGGGGGGGGGGGGACAAGGGGGGCGGGGGCAGGAAAGCACGGGGGGA 
  901 CGGCGGGGAAAAGGGAACGGGGAGGGGGGGGGGAAACGGGCAAGGGGGGG 
  951 GGGGGTGGGGGGAAACGGGGGGGGAAGGGGCGAACACGGGGAACGGGGGA 
  1001 CAGCGGGGGGGGGGGGGGCACGGGGGGGGAAGGGGACGGGGACAGGGGGG 
  1051 GGACCGGGGGAAGGGAAACGGGGGAAGGGGGGACCCCGGGGAAGGGGGCA 
  1101 GGGGGACGGAGGGGGAA 
Figure 3.1: Sequence of the 5’RACE PCR product (3’-5’ orientation) from the W097E01 ES cell line. Blue 
colour: 5’ part of gene trap vector (pT1ßgeo), green: exon 1 of Sall4, red: unspecific sequence generated by 5’ 
RACE. 
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3.1.2 Localisation of the gene trap vector integration site in Sall4 gene 
 
The integration site of the gene trap vector was determined by comparison of the Sall4 cDNA 
sequence with the sequence of the 5’ RACE PCR. The gene trap insertion occurred within 
intron 1, between exon 1 and exon 1a (Fig. 3.2). To identify the exact insertion site of the gene 
trap vector in the genomic DNA, a PCR-based approach was used. The mutant locus was 
amplified using primers derived from exon 1, intron 1, exon 2 and gene trap vector (Fig 3.2B). 
Primers in the intron 1 were designed every 1000 bp in order to cover the full length of 10 kb 
genomic sequence (Table 3.1).  
 
5’ part of the insertion 3’ part of the insertion 
Forward primer Reverse primer Forward primer Reverse primer 
S4ME1F1 
S4ME1F2 
S4ME1F3 
S4MI1F4 
S4MI1F5 
S4MI1F6 
S4MI1F7 
S4MI1F8 
S4MI1F9 
S4MI1F10 
S4MI1F11 
S4MI1F12 
S4MI1F13 
S4MI1F14 
pGeoR1 
pGeoR2 
pGeoF1 
pGeoF2 
pGeoF3 
pGeoF4 
S4ME2R1 
S4ME2R2 
S4ME2R3 
S4MI1R1 
S4MI1R2 
Table 3.1: Primers which were used in different combination to amplify 5’ part of the insertion and 3’ part of the 
insertion. 
 
Amplification with primers S4ME1F2 and pGeoR1 revealed a fragment of 878 bp. After 
sequencing of this fragment the insertion of gene trap vector was localized 208 bp 3’ from 
exon 1 (Fig 3.2). In the integration site of the gene trap vector it was small deletion of the 
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Sall4 intron 1 sequence (14 bp). Also if was found that 1340 bp Engrailed 2 intron sequence of 
the pT1βgeo vector was deleted. 
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gure 3.2: (A) Localisation of gene trap vector by PCR amplification of 5’ part of the insertion. PCR products 
ere used for sequencing and further analysis. (B) Schematic representation of gene trap vector pT1ßgeo 
tegration locus in Sall4 gene. Only first three exons are shown. Integration occurred in the intron 1 between 
on 1 and exon 1a. Transcription of mutated Sall4 is presumably stopped by a polyadenylation signal at the 3’ 
d of gene trap vector. Deletions of the intronic sequences in the genomic DNA and in the vector are marked 
ith arrows. Positions of primers are marked by arrowheads. 
all4 
T1ßgeo 
1 2 
21 bp 
1340 bp del 
8292 bp  2367 bp 1780 bp 
 En2 LacZ/neo pA
       1a
E1F1 E1F2 E1F3 I1R1 I1R2 I1F5 I1F6 I1F7 I1F8 I1F9 I1F10 I1F11 I1F12 I1F13 I1F14 I1F4 E2R1 E2R2 E2R3 
pF2 pR1 pF1 pF4 pR2 pF3 
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3.2 Characterisation of Sall4 splicing forms 
 
The Sall4 gene was first described by Kohlhase et al. (2002). At that time only one transcript 
variant of Sall4 was known with 4 exons encoding a protein of 1067 aa in length. Comparison 
of mouse ESTs with the mouse Sall4 coding sequence (NM_175303) revealed several highly 
homologous EST sequences. The 3’ part of the BY729264 sequence showed similarity to exon 
2 of Sall4 but the 5’ end showed similarity to a putative exon in intron 1. Moreover this 
sequence contained a predicted translation initiation site and possible splice acceptor 
sequences. These data have suggested the presence of another 5’ exon localized in intron 1, 
named 1a, which was downstream of exon 1 in Sall4 (Fig. 3.3). An extensive analysis of the 
all reported EST, of Sall4 in the database detected transcripts containing either exon 1 or exon 
1a suggesting the presence of two alternative spliced forms of Sall4. 
 
        1 gggtcggagc ccggcctctg gcgtgcgggc gccctctgga gaccggccat gtgcggactg 
       61 cgacacacac ctggtgctcc agtgaactcc cctgggaact gcgatgaagc ctcagaggac 
      121 tccataccgg tgaagcggcc ccggcgggag gacactcaca tctgcaacaa atgctgtgcc 
      181 gagttcttta gtctctctga attcatggaa cacaagaaaa gttgcactaa aacccctcct 
      241 gtcctcatca tgaatgacag cgaggggcca gtgccttcag aggacttttc cagagctgcc 
      301 ctgagccacc agctgggcag cccaagcaat aaagacagtc tccaggagaa cggcagcagc 
      361 tcgggggact tgaagaagct gggcacggac tccatcctgt acttgaagac agaggctacc 
      421 cagccatcca caccccagga cataagctat ttacccaaag gcaaagtagc caacaccaat 
      481 gtgactctgc aggcgctccg gggaccaagg tggccgtgaa ccaacggggt gcagaggcac 
      541 ccatggcgcc catgcctgct gcccaggcat cccttggggc ctggagcaga tcctgggcct 
      601 gcagcaggag ccacttccgc aaagccgctt acggaacaga tcccgtccag gtgacatgtg 
 661 ggca 
Figure 3.3: EST sequence (BY729264) showing a new alternative splice variant of Sall4. Black colour: sequence 
of the predicted alternative exon 1a, red: exon 2 sequence. Note that the exon 2 sequence is in frame with the 
exon 1a sequence harbouring an alternative predicted start codon ATG (underlined). 
 
To confirm the presence of predicted two alternative first exons, RT-PCR with total RNA 
from E8.5 embryos was performed. Primers S4ME1F1 and S4ME2R2 were used to amplify 
transcript with exon 1 and primers S4ME1aF1 and S4ME2R2 – to amplify transcript with 
exon 1a. (Fig. 3.4). Two RT-PCR products of different length were purified from the agarose 
gel and sequencing of the two products confirmed the presence of two Sall4 splice variants. 
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1010 bp 
904 bp 
Figure 3.4: RT-PCR analysis with total RNA isolated from E8.5 mouse embryos using Sall4 specific primers. 
Lane 1: PCR product from exon 1 – exon 2 transcript (1010 bp), lane 2: PCR product from exon 1a – exon 2 
transcript (904 bp), lane 0: negative control for PCR.  
 
The Sall4 major transcript consists of 4 exons. The Sall4 minor transcript variant contains 
alternative exon 1a instead of exon 1 (Fig 3.5), which was spliced in frame to the exon 2 
sequence. 
 
    2  gtttcggccgaagggggctaaaatttcccaactccaggaattggtggcggagagggggca 
   62  agtcaccagggctcttcccggcgccccaatgcgcgcaccatgtcgaggcgcaagcaggcg 
                                               M  S  R  R  K  Q  A  
  122  aagccccagcacatcaactgggaggagggccagggcgagcagcctcagcagctaccgagc 
        K  P  Q  H  I  N  W  E  E  G  Q  G  E  Q  P  Q  Q  L  P  S  
  182  cccgacctcgccgaggcgctggcggcggaggaacccggtgagtgcggctgcggccacgtc 
        P  D  L  A  E  A  L  A  A  E  E  P  G   
  242  cgtgcgcccgactgtccgtgcgtcccgggagggcgctcctagcactgccgcgcgtccctc 
  362  gagggcgcgggttccgggagccgattctggaatggggattccggactctgttccaggaaa 
  422  ggaga atgcggagggagggagcctcaatcccccacctcggagggagcctcaacccgccc 
  482  acccc ttgcaaatccccctagttttctccctcttattgtaaagttgattccacattctg 
  542  cctct
  602  ataca
 1802  ...tt
 1862  ggtgg
 1922  atctc
 1982  tgcca
 2042  tggcg
            
 2102  tgagg
10271  ...tg
10328  ggtgc
        G  A
10388  aagcg
        K  R
10448  ctctc
        L  S
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ccctccaacttctctctcctcgtccacagtcccataattggtttccctcctttgg 
taagcacccacctacgccggtaacttgggcttccttcaccccctctctagtg... 
ggggtgagcgcatactagtgttttttgttttgtttttttctcctatttagctggt 
ggactctgggggtgggcggcatggagaggtggcttgctatagaagggcttccgaa 
cgctggctggagtcgtagttaacctggctgcaccctgaggccgctgggcgcgcgc 
cccagccttgggaagcgagttttctgcggatcactcgcggtcggagcccggcctc 
tgcgggcgccctctggagaccggccatgtgcggactgcgacacacacctggtgag 
                          M  C  G  L  R  H  T  P  G     
ttagctaggccggagacccgcacacgcgtgatctctgtggggtccccatctt... 
gtcacttgacatcccttctcagggcatcctgctcacctttttctctcctttcaca 
tccagtgaactcccctgggaactgcgatgaagcctcagaggactccataccggtg 
  P  V  N  S  P  G  N  C  D  E  A  S  E  D  S  I  P  V  
gccccggcgggaggacactcacatctgcaacaaatgctgtgccgagttctttagt 
  P  R  R  E  D  T  H  I  C  N  K  C  C  A  E  F  F  S  
tgaattcatggaacacaagaaaagttgcactaaaacccctcctgtcctcatc... 
  E  F  M  E  H  K  K  S  C  T  K  T  P  P  V  L  I   
mic sequence of Sall4 gene including exon 1, intron 1, exon 1a and partial sequence of exon 2. 
g amino acid sequence of exon 1 (blue), exon 1a (red) and exon 2 (orange) is represented below 
nscription start sites are underlined. Gene trap vector integration site is marked with asterisk. 
e genomic sequence in the site of integration is marked with green.   
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Search of the GenBank database at NCBI (http://www.ncbi.nlm.nih.gov) revealed the 
description of two additional transcript variants (NM_201395, NM_201396). These transcripts 
are either missing 3’ sequence of exon 2 (isoform b) or the complete sequence of exon 2 
(isoform c). In the context of our project, we focused our investigation on the Sall4 major and 
Sall4 minor transcript variants only (Fig. 3.6). 
 
Figure 3.6: Schematic representation of the genomic organization and splicing forms of the Sall4 gene. The Sall4 
major transcript consists of 4 exons. The Sall4 minor transcript variant contains alternative exon 1a instead of 
exon 1. Isoform b consists of 4 exons, but includes only 5’ part of exon 2. Isoform c includes 3 exons completely 
missing exon 2.  
 
3.3 Expression analysis of Sall4 
 
3.3.1 Expression of Sall4 gene in preimplantation embryos 
 
The expression of Sall4 gene in blastocyst stage embryos was studied by X-gal staining (Fig. 
3.7). Embryos were obtained from crosses between Sall4 heterozygous males and wild type 
females. Blue β-galactosidase staining in blastocyst stage embryos was detected in the inner 
cell mass and in the trophectoderm of heterozygous embryos. The staining was not detected in 
wild type embryos. 
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Figure 3.7: Expression of Sall4 in mouse preimplantation stage embryos. (A) Expression of β-galactosidase was 
detectable both in the inner cell mass (ICM) and in the trophectoderm (T) of heterozygous embryos. (B) Wild 
type embryos were used as a negative control. 
 
3.3.2 Expression of Sall4 gene in postimplantation embryos 
 
Sall4 expression studies using whole mount in situ hybridisation on mouse embryos were 
previously described by Kohlhase et al. (2002b). X-gal staining was performed in order to 
confirm the expression pattern of Sall4 and to show the proper function of the gene trap vector 
in tissues where the “trapped” gene is known to be expressed. 
X-gal staining was detectable as early as E7.5 stage (Fig. 3.8). Strong Sall4 expression was 
found in the primitive streak, cardiac crescent and lateral plate mesoderm. At E8.5 strong 
expression was found in the cephalic neural fold, early somites, primitive streak and allantois. 
At E9.5 stage, when the neural tube begins to close at the level of forebrain/midbrain, Sall4 
expression became more confined to the midbrain, but strong expression remains in the more 
caudal region of neural tube. Transient Sall4 expression was observed in the region of first 
branchial arch, region of future heart outflow tract (Fig 3.8). By the E11.5 stage, diminished 
Sall4 expression was observed in several embryonic regions, including midbrain, 
rhombomers, limb bud mesenchyme and genital papilla. 
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Figure 3.8: Whole mount X-gal staining of Sall4 heterozygous embryos during early postimplantation 
development. (A) E7.5, Sall4 expression is in the primitive streak. (B) E8.5, Sall4 expression is in the neural fold, 
early somites, primitive streak and allantois. (C) E9.5, Sall4 expression became more confined to the midbrain 
and strong expression remains in the caudal region of neural tube. (D) E11.5, Sall4 expression remains in the 
midbrain, limb buds mesenchyme and genital papilla. ps – primitive streak, cc – cardiac crescent, hf – head fold, 
h – heart, tb – tail bud, s – somites, mb – midbrain, ba – branchial arch, fl – fore limb bud, hl – hind limb bud, gp 
– genital papilla. 
 
To verify in which cell types Sall4 is expressed, embryos were sectioned after whole mount X-
gal staining on a cryotome and counterstained with Fast red (Fig. 3.9). In E7.5 embryos X-gal 
staining was observed in the embryonic mesoderm (region of future myocardial plate) and 
allantois. Some amnionic cells were also X-gal positive. Sall4 expression was also seen in the 
neural epithelium and was particularly notable in the neural crest cells immigrating from the 
hindbrain of E8.5 stage. The strongest expression of Sall4 during neural crest cell migration 
was found in the dorsal and lateral portion of the branchial arch. At the spinal cord level Sall4 
is expressed throughout the neural tube, mostly in the dorsal region. At later E8.75 stage, X-
gal staining was found only in those neural crest cells, which will form pericardial cavity and 
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outflow tract of the heart. In the neural fold Sall4 is expressed in the medial part in neural 
epithelium and caudal dorsal neural tube.  
 
 
Figure 3.9: Transverse cryosections through whole mount X-gal stained Sall4 embryos, counterstained with Fast 
Red. (A) E7.5, Sall4 expression in the mesoderm and allantois. (B) E8.5, Sall4 expression is notable in the neural 
epithelium and in migrating neural crest cells. (C) E8.75, Sall4 is expressed in the medial part on neural 
epithelium, caudal neural tube and in the migrating neural crest cells likely forming pericardial cavity and 
outflow tract. Migrating neural crest cells are marked with arrowhead. m; mesoderm, pc; pericardial cavity, ht; 
heart, fg; foregut, nt; neural tube. 
 
3.3.3 RT-PCR analysis of Sall4 expression during embryonic development 
 
The tissue-specific expression of the mouse Sall4 gene was first determined by Northern blot 
analysis with total RNA prepared from different tissues. A single transcript of size 5.4 kb was 
observed only in testis and ovary (Kohlhase et al., 2002b). Here, expression analysis of Sall4 
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during embryonic development was performed by RT-PCR with total RNA of mouse embryos 
from different stages (Fig. 3.10). 
 
Figure 3.10: RT-PCR analysis with total RNA isolated from whole mouse embryos of different developmental 
stages using Sall4 specific primers. Primers S4ME1F1 and S4ME2R2 were used to amplify exon 1-2  transcript, 
primers S4ME1aF1 and S4ME2R2 – to amplify exon 1a-2 transcript and primers S4ME2F2 and S4ME4RTR – to 
amplify exon 2-4 transcript. The splice variants Sall4 major (exon 1-2) and Sall4 minor (exon 1a-2) are 
compared. Exon 2-4 RT-PCR detects both variants. RT-PCR for Gapdh transcript was performed as a control for 
RNA amount and integrity. Note that strongest expression of Sall4 minor variant was found at E7.5 and almost 
not detectable at E14.5. Sall4 major expression was observed until E16.5. Exon 2-4 transcript expression was 
detectable until E16.5.  
 
Analysis of embryonic mRNAs by RT-PCR confirmed expression of transcripts derived from 
the two alternative 5’ coding exons. Expression for both transcripts was detectable as early as 
E7.5 and gradually decreases until E17.5. Sall4 minor variant showed a limited expression 
period and was almost not detectable at E14.5 stage. The expression of Sall4 major transcript 
variant was observed until E16.5. However the expression of exon 2-4 transcript which detects 
both variants was detectable until E16.5.  
 
3.3.4 Expression of splicing variants in Sall4 mutant mice 
 
In order to determine whether the gene trap vector insertion leads to a null mutation or to a 
hypomorphic allele, quantitative real-time RT-PCR was performed. Total RNA was isolated 
from E8.5 stage embryos and cDNA was prepared by reverse transcription using oligo(dT) 
primers. The expression of Sall4 transcripts was analysed by using a SYBR Green assay and a 
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standard curve method as described in chapter 2.2.7. The expression level of investigated 
transcripts was normalised to ß-actin mRNA expression to compensate for difference in 
sample amounts (Fig. 3.11). 
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Figure 3.11: Total RNA was isolated from E8.5 wild type (+/+), heterozygous (+/-) and homozygous (-/-) Sall4 
embryos and analysed by real-time RT-PCR. The expression level was normalised to ß-actin expression. 
Expression levels in wild type embryos for each transcript are set to 100%. Exon 3-4 product detects both 
transcripts. Note that expression of major transcript in +/- embryos is 58% less and in -/- embryos is 98% less 
than in wild type. The expression level in case of minor transcript is reduced by 27% in +/- embryos and by 55% 
in -/- embryos as compare to wild type. Exon 3-4 transcript represents total amount of both transcripts and is 
reduced in +/- embryos to 50% and in -/- embryos to 10%.  
 
Relative expression of Sall4 major and Sall4 minor transcripts was compared between wild 
type, heterozygous and homozygous mutant mice. Real-time RT-PCR analysis revealed that 
the level of the major transcript in heterozygous animals was reduced by 58% as compared to 
wild type; in contrast, the level of reduction in case of minor transcript was only 27% in 
heterozygous animals. Real-time RT-PCR showed presence of approximately 2% of major 
transcript and 45% of minor transcript in Sall4 homozygous embryos. Exon 3-4 transcript 
represents total amount of both transcripts and was reduced in +/- embryos to 50% and in -/- 
embryos to 10%.  
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3.4 Phenotype of Sall4 mutant mice 
 
After identification of the genomic localization of the gene trap insertion, primers were 
designed for a genotyping PCR. The gene trap construct had been electroporated into ES cells 
originating from the mouse strain 129X1/SvJ, but the mouse line created was crossed to the 
C57BL/6J background. Therefore, the genome from the Sall4 mouse line was of the mixed 
129X1/SvJxC57BL/6J background.  
ES cells from the GGTC line W097E01 were injected into inner cell mass of blastocysts 
derived from 129X1/SvJ mice at the GGTC facility. Chimeras were bred with C57BL/6J mice 
to obtain F1 animals. We received such F1 animals. Further breeding was performed by 
mating F1 animals with C57BL/6J wild type animals. The germline transmission was checked 
by genomic PCR with S4MI1R1a, pGeoR6, S4I1F1 primers (Fig. 3.12). 
                         
284 bp 
234 bp 
+ - wild type allele 
- - gene trap allele 
M         0        +/+      +/- 
Figure 3.12: PCR genotyping of the Sall4 mouse gene trap line W097E01. The wild type allele for Sall4 is 
amplified by S4I1F1 and S4MI1R1a primers resulting in a PCR product of 284 bb. The trapped Sall4 allele 
expected size is 234 bp using the primers S4I1F1 and pGeoR6. +/+ - wild type; +/- - heterozygous; 0-negative 
control, M-1 kb marker. 
 
3.4.1 Early embryonic lethality of Sall4 mice 
 
We chose the Sall4 gene trap mouse line in order to investigate the function of Sall4 and to use 
it as a model system for Okihiro syndrome. Sall4 heterozygous mice obtained from 
backcrossing with wild type animals were firstly checked for the presence of anomalies 
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similar to the symptoms observed in Okihiro syndrome patients. This would imply defects of 
the upper limb, especially on the radial side, heart defects, renal anomalies and a missing 6th 
cranial nerve or its nucleus. The morphological and histological analysis of the brain as well as 
a histological analysis of heart, liver, muscle and kidney was done by Dr. Walter Schulz-
Schaeffer, Dept. of Neuropathology, University of Göttingen, and revealed no abnormalitities. 
Gross morphological analysis of the heterozygous mice revealed no abnormalities in skeleton, 
brain, kidney, muscles and heart. Heterozygous mice were also fertile. Genotyping analysis of 
the F2 generation revealed that 37% of the offspring were wild type and 63% were 
heterozygous. No homozygous mutant mice were detected suggesting embryonic lethality 
(Table 3.2). 
 
 +/+ +/- -/- total 
♀ 24 32 0 56 
♂ 22 44 0 66 
total 46 (37%) 76 (63%) 0 (0%) 122 
Table 3.2: Genotyping of newborn offspring resulting from intercross breeding of Sall4 heterozygous mice. 
 
To determine the time of embryonic lethality, embryos of different developmental stages were 
isolated from heterozygous intercrosses and genotypes were determined by PCR (Table 3.3). 
 
 +/+ +/- -/- total 
E3.5 14 20 8 42 
E7.5 7 9 1* 17 
E8.5 10 30 9* 49 
E9.5 8 21 8† 37 
E10.5 1 3 2† 6 
Table 3.3: Genotyping of the embryos from different developmental stages from breeding of Sall4 heterozygous 
mice. * - malformed embryos, † - reabsorbed embryo tissue. 
 
At stage E3.5, 8 homozygous embryos were found, indicating that development of the 
embryos during preimplantation step occur normal. At the later stages (E7.5-E8.5) 
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homozygous embryos were smaller and malformed. After stage E9.5, only residual parts of the 
amnion of homozygous embryos were present in the uterus. Sall4 homozygous mutant 
embryos were developing normally up to E7.0 stage, thereafter development was severely 
retarded and they were reabsorbed by E9.5 stage. 
 
3.4.2 Phenotype of Sall4 homozygous embryos 
 
Sall4 homozygous embryos appeared to develop normally until E7.0, but failed to develop 
properly during later stages of development. Homozygous embryos were smaller and showed 
a lack in the development and formation of primary structures in the embryos (Fig. 3.13). 
 
-/- +/-
 
Figure 3.13: Morphology of heterozygous and homozygous mutant Sall4 embryos at E8.5 using X-gal staining. 
The homozygous mutant embryo appears severely malformed and smaller than the heterozygous due to 
developmental arrest. 
 
3.4.3 Histological analysis of Sall4 embryos 
 
In order to understand the underlying cause of the early embryonic lethality, Sall4 
homozygous mutant embryos were analysed histologically at different stages and compared 
with wild type littermates. E7.5 embryos were smaller than their littermates and demonstrated 
abnormalities in primitive streak, amnionic cavity and allantois (Fig. 3.14)  
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Figure 3.14: Histological analysis of Sall4 E7.5 embryos. Sagittal sections of paraffin embedded E7.5 wild type 
(A) and homozygous (B) embryos were stained with haematoxylin-eosin. all, allantois; epc, ectoplacental cone; 
ps, primitive streak. 
 
Homozygous mutant E8.5 embryos appeared developmentally retarded as compared to their 
littermates (Fig. 3.15). The neural tube of the homozygous E8.5 embryos remained open. The 
foregut region which plays an important role during heart development was deformed in 
shape. However the most severe phenotypic abnormality was in the heart region. Normal heart 
development starts with two heart fields at E7.5 which are fusing at later stages to form a 
tubular heart. In E8.5 wild type embryos, parts of the heart were already fused forming a 
primitive heart with a pericardial cavity (Fig. 3.15A). In contrast, in homozygous mutant 
embryos the heart was not formed properly, the heart bulbs were not fusing and the pericardial 
cavity was underdeveloped. The embryonic lethality of Sall4 homozygous mutant embryos 
during early gestation could therefore result from cardiac bifida together with the deformation 
of the foregut and missing neural tube closure. 
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Figure 3.15: Haematoxylin-eosin staining of E8.5 embryos. Transverse sections through wild type (A) and Sall4 
homozygous mutant (B) embryos. Homozygous embryos fail to form a primitive heart by fusion of two heart 
bulbs. nt, neural tube; fg, foregut; h, heart.. 
 
3.4.4 Analysis of cellular proliferation in Sall4 embryos 
 
To identify whether the Sall4 mutant phenotype was due to a cell proliferation problem, BrdU 
labelling was performed. BrdU labelling provides a simple technique for the identification of 
proliferating cells. To measure the BrdU incorporation in mouse embryos, pregnant females 
were given a single dose of BrdU through intraperitoneal injection (chapter 2.2.14). No 
difference in cellular proliferation between wild type and homozygous mutant embryos was 
observed (Fig. 3.16).  
 
 
B A 
Figure 3.16: BrdU staining of formalin fixed, paraffin embedded E8.5 embryos. No obvious difference between 
wild type (A) and homozygous (B) embryos was observed. 
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To check whether Sall4 mutant phenotype was caused by developmental arrest or by a 
proliferation problem, E3.5 embryos were cultivated for 5 days. The phenotype of the cultured 
blastocysts was documented daily by inverted microscope (Fig. 3.17). In total, 25 blastocysts 
were analysed. There was no significant difference in cell growth and development of both 
inner cell mass and trophectoderm between wild type, heterozygous and homozygous 
blastocysts. This result suggests that during preimplantation step Sall4 mutant embryos are 
developing normal. 
 
E3.5+1 E3.5+3 E3.5+5 
 
t 
icm 
t 
icm 
Figure 3.17: Growth of Sall4 embryos in the culture. Blastocysts (E3.5) derived from heterozygous intercrosses 
were cultured for 5 days and photographed at the 2nd (E3.5+1), 3d (E3.5+2) and 5th day (E3.5+5) of culture. icm, 
inner cell mass, t, trophoblast. 
 
3.5 Sall4 regulates the expression of Pax3 and T-box genes 
 
Numerous signalling molecules and pathways regulate early embryogenesis. To determine 
which genes are misregulated in Sall4 mutant embryos, we analysed their expression using 
whole mount in situ hybridisation and real-time RT-PCR approach. 
Pax3 could serve as early embryonic marker of neuroepithelium for in situ hybridisation 
studies. Mutations in Pax3 cause open neural tube phenotype (Epstein et al., 1991), which was 
also observed in Sall4 mutant embryos. In the wild type embryos Pax3 expression was 
detected in the dorsal part of the neural tube and in the lateral epithelium of the proencephalon 
(Fig. 3.18). In the homozygous mutant embryos Pax3 expression was not detectable.  
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A B 
-/-+/+
Figure 3.18: Pax3 expression in wild type (A) and in Sall4 homozygous mutant (B) E8.5 embryos analyzed by in 
situ hybridization. (A) Pax3 expressed in the dorsal part of the neural tube (arrow) and in the proencephalon. (B) 
No Pax3 expression in mutant embryo was observed. Scale bar 300 µm. 
 
The brachyury (T) gene is an early mesodermal marker involved in notochord formation 
(Wilkinson et al., 1990). The phenotype of brachyury mice includes disruption of trunk 
development and embryonic death in homozygotes. In wild type and heterozygous E7.5 
embryos brachyury is exclusively expressed in the mesoderm of the primitive streak (Fig. 
3.19A, B). In contrast, in homozygous Sall4 mutant embryos brachyury expression was 
diffuse and ectopically localised (Fig. 3.19C, D). 
 
 
B A C 
D 
Figure 3.19: Expression of brachyury in E7.5 embryos by whole mount in situ hybridization (detection with 
INT/BCIP). Wild type (A) and heterozygous Sall4 mutant (B) embryos show similar expression patterns in the 
mesoderm of primitive streak. Note diffuse misexpression in homozygous mutants (C, D). Scale bar 200 µm. 
 
The genes Tbx1 and Tbx5 like brachyury belong to the T-box gene family (Tbx) and have 
been implicated in early cardiac lineage determination, chamber specification, and 
valvuloseptal development (Chapman et al., 1996; Simon, 1999). Heterozygous mutation of 
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mouse Tbx5 causes aberration of cardiac development (linear heart) and embryonic lethality as 
well as severe upper limb defects (Bruneau et al., 2001; Zhou et al., 2005). Tbx1 mutations 
have been implicated in the etiology of cardiac outflow tract and pharyngeal arch anomalies 
(Merscher et al., 2001). The regulation of these genes plays an important role during primitive 
heart formation. Therefore, expression of the T-box genes brachyury, Tbx1 and Tbx5 was 
examined in Sall4 mutant embryos. At E8.5 stage, embryos were collected in separate tubes. 
RNA and DNA of single embryos were isolated using TRI reagent. Embryos were genotyped 
and cDNA was synthesised with oligo(dT) primers. The expression of brachyury, Tbx1 and 
Tbx5 was analysed by quantitative real-time RT-PCR using SYBR Green dye. Expression 
level in all samples was normalised to ß-actin expression (Fig. 3.20). 
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Figure 3.20: Total RNA was isolated from E8.5 wild type, heterozygous and homozygous Sall4 mutant embryos 
and analysed by real-time RT-PCR for brachyury, Tbx1 and Tbx5 expression relative to ß-actin expression. 
Expression levels in wild type embryos for each gene are set to 100%. 
 
Expression of the three T-box genes was largely reduced in the Sall4 homozygous embryos. 
Brachyury expression level was diminished by 45%. Expression of Tbx1 and Tbx5 was 
lowered to around 6% of the wild type level. In contrast, expression of these genes was almost 
unaffected in Sall4 heterozygous embryos. 
 
3.6 Sall4 antibody generation 
 
Polyclonal antibody was generated against Sall4 fusion protein as described in methods part. 
In order to determine the affinity and specificity of the antiserum, Western blot analysis was 
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performed. Total protein extracts from several tissues and from whole E9.5 embryos was used 
to detect Sall4 expression. The antiserum derived from rabbit showed a lot of unspecific bands 
and the affinity of the antibody against the Sall4 epitope was very weak (Fig. 3.21A). Protein 
G purification was performed to enrich IgG fraction of antiserum and to increase the 
concentration of the Sall4 antibody (Fig. 3.21B), but the titer of antibody was too weak to get 
a consistent result. 
 
A C B 
Figure 3.21: Western blot analysis with polyclonal antibody against Sall4 protein. In this analysis antibody 
dilution 1:150 was used. (A) Unpurified antiserum showed high cross-reactivity to other proteins. (B) Protein G 
purified antibody. (C) Affinity purified antibody detected a 113 kDa band corresponding to the predicted Sall4 
protein size. br, brain; tes, testes; E9.5, embryo E9.5 stage.  
 
In order to obtain a high titre antibody, affinity purification of antiserum was performed. The 
fusion protein used for rabbit injections was coupled with NHS-HiTrap column and antiserum 
was passed through the column. Antibody fractions were eluted from the column, dialysed 
against PBS and concentrated using a Centrisart column. A specific band corresponding to 
molecular weight of 113 kDa of Sall4 was detected by Western blot (Fig. 3.21C). To check the 
specificity of anti-Sall4 antibodies, a Western blot analysis with the F9 cell line, which 
expresses Sall4 endogeneously, was performed (Fig. 3.22). A single specific band of 113 kDa 
was detected. 
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113 kDa 
Figure 3.22: Western blot analysis of F9 cell line with polyclonal antibody against Sall4 protein. In this analysis 
an antibody dilution of 1:150 was used. Affinity purified antibody detected a 113 kDa band corresponding to the 
Sall4 protein. 
 
3.7 Sall4 and Sall1 interaction studies 
 
3.7.1 Interaction on the genetic level 
 
The genes Sall1 and Sall4 belong to the family of SAL-like genes, named after the gene sal 
(spalt) of D. melanogaster (Kühnlein et al., 1994). They show an overlapping expression 
pattern during development (Buck et al., 2000, Kohlhase et al., 2002b). From the previous 
studies it was known that some of the SALL family genes can interact in vitro with other SALL 
family members in mouse and chicken (Kiefer et al., 2003, Sweetman et al., 2003) and form 
homo- and heterodimeric complexes.  
To further evaluate the functional interaction between Sall1 and Sall4 we initiated generation 
of double knockout mice. A Sall1 knockout mouse line on 129X1/SvJ background had been 
previously established in our group (Buck, 2002). Sall1 heterozygous mice appeared to be 
normal and homozygous mice were dying in the perinatal period because of severe kidney 
defects leading to uremia, analogous to the phenotype of the published Sall1 knock-out mice 
(Nishinakamura et al., 2001). In Sall4 heterozygous mutant mice no obvious phenotype was 
observed and homozygous mice were dying before E7.5. The deviation of genotype to 
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Mendelian inheritance can reflect an interaction between two genes. In double heterozygous 
breedings it was expected to observe changes in the lethality or phenotype of                    
Sall1(-/-)/Sall4(+/-) and Sall1(+/-)/Sall4 (-/-) offspring (Fig. 3.23). 
 
Sall1/Sall4 Sall1/Sall4 
(+/-)  (+/-) (+/-)  (+/-)  X 
♂ ♀ 
Sall1/Sall4 1. newborns (?) 
(-/-) (+/-) 
Sall1/Sall4 2. E7.5 (?) 
(+/-)  (-/-) 
Sall1/Sall4 E7.5 (?) 3. 
(-/-)  (-/-) 
                                                          
Figure 3.23: Schematic representation of the strategy to generate Sall1/Sall4 double mutant mice. 
 
To generate double heterozygous animals, Sall1 heterozygous mutants and Sall4 heterozygous 
mutants were crossed. However, genotyping analysis of Sall1/Sall4 offspring revealed an 
obvious deviation from Mendelian inheritance ratio (Table 3.4). 
 
Sall1 (+/-) Sall4 (+/-) X 
Genotype Sall1/Sall4 
(+/+) (+/+) 
Sall1/Sall4 
(+/+) (+/-) 
Sall1/Sall4 
(+/-) (+/+) 
Sall1/Sall4 
(+/-) (+/-) 
Mendelian ratio 25% 25% 25% 25% 
Offspring number 24 24 25 2 
Offspring ratio        32%        32%        33.3%       2.7% 
Table 3.4: Genotyping analysis of Sall1 +/- mutant/ Sall4 +/- mutant breeding. The total amount of genotyped 
animals was 76. P<0.0001 
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Sall1(+/-)/Sall4 (+/-) was noticeably reduced. The two-tailed P value was less than 0.0001. By 
conventional criteria, this difference is considered to be extremely statistically significant. 
 
3.7.2 Co-localization of Sall4 with truncated Sall1 protein in F9 cells 
 
The N-terminally truncated Sall1 protein, expected to be generated by typical SALL1 
mutations in Townes-Brocks syndrome patients, can exert a dominant negative effect (Sato et 
al., 2004). Truncated Sall1 protein is able to interfere with the correct function of native Sall1 
protein by causing its displacement from the nucleus (Sweetman et al., 2003). For the 
interaction study, a Sall1 N-terminal part encoding amino acids 1-435 was cloned into 
pcDNA3.1 vector. The subcellular distribution of the endogenous Sall4 protein and the 
possible co-localisation with the N-terminally truncated Sall1 (Sall1tr) protein in mouse F9 
teratocarcinoma cells were analysed by immunocytochemical studies. F9 cells were transiently 
transfected with the myc-tagged Sall1tr construct and the expression of proteins was 
determined by staining with anti-Sall4 and anti-c-myc antibodies. A signal of the Sall4 protein 
was detected exclusively in the nucleus of the stained cells (Fig. 3.24). 
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Figure 3.24: Subcellular localization of the Sall4 protein in F9 cells. (A, C) F9 cells stained with polyclonal anti-
Sall4 antibody and anti-rabbit Cy3-coupled antibody; (B, D) merged picture with DAPI staining. 
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The staining pattern for the Sall4 in the nucleus is similar to that known for other members of 
Sall family present in a punctuate pattern probably representing pericentromeric 
heterochromatin (Netzer et al., 2001; Kiefer et al., 2002; Sato et al., 2004). In contrast, 
transient transfection of F9 cells with myc-tagged Sall1tr construct revealed a clear change in 
the subcellular localization of Sall4 protein. In the presence of Sall1tr, Sall4 was detected in 
the cytoplasm co-localising with Sall1tr protein (Fig. 3.25). This result suggests that Sall1tr 
can interact with Sall4 protein by changing localisation of the endogenous Sall4 protein. 
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Figure 3.25: Endogenous Sall4 co-localised in the cytoplasm with truncated Sall1 protein in F9 cells. (A) 
Truncated Sall1 protein was detected by staining with polyclonal anti-myc and anti-rabbit FITC-conjugated 
antibody. (B) Sall4 protein with polyclonal anti-Sall4 antibody and anti-rabbit Cy3-coupled antibody. (C) DAPI. 
(D) merged picture. 
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4. DISCUSSION 
 
The present work discusses the identification and characterisation of Sall4 gene trap mouse 
line. The following results were obtained: 
• Sall4 gene trap ES cell line was identified by comparing Sall4 sequences to the 
database of the German Gene Trap Consortium. This ES cell line was used for 
blastocyst injection and generation of Sall4 gene trap mouse line. 
• New splicing isoform of Sall4, named Sall4 minor, was isolated by EST database 
analysis and confirmed by RT-PCR and sequencing. 
• Expression of Sall4 major and Sall4 minor transcript variants during embryonic 
development was analysed. It was demonstrated that expression for both transcripts 
was detectable as early as E7.5 and gradually decreases until E17.5. Sall4 minor 
variant was expressed until E14.5 stage, while the expression of Sall4 major transcript 
variant was observed until E16.5. 
• During embryonic development Sall4 expression was found at blastocyst stage in the 
inner cell mass and in the trophectoderm. At later stages Sall4 expression was found in 
the primitive streak, neural tube, developing brain, branchial arches and limb buds. 
• X-gal staining revealed expression of Sall4 in the intraembryonic mesoderm, neural 
epithelium and migrating neural crest cells. 
• Expression of Sall4 major and Sall4 minor transcript variants in Sall4 mutant mice was 
analysed by quantitative real-time RT-PCR. The expression level of major transcript in 
heterozygous embryos was 58% less and in homozygous embryos was 98% less than 
in wild type. The expression level in case of minor transcript was reduced by 27% in 
heterozygous embryos and by 55% in homozygous embryos as compared to wild type. 
• Sall4 heterozygous mice revealed no abnormalities, but homozygous embryos were 
severely retarded and die around E7.5. 
• The embryonic lethality of Sall4 homozygous mutant embryos during early gestation 
results from cardiac bifida together with the deformation of the foregut and missing 
neural tube closure. 
• Whole mount in situ hybridisation revealed absence of the Pax3 expression in Sall4 
homozygous mutant embryos and ectopical expression of brachyury. 
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• By real-time RT-PCR it was demonstrated that expression of T-box genes brachyury, 
Tbx1 and Tbx5 was downregulated in Sall4 homozygous mutant embryos, but not in 
the heterozygotes. 
• Generated polyclonal anti-Sall4 antibody can specifically detect Sall4 expression in the 
Western blot analysis and in immunocytochemical analysis. 
• Sall4 and truncated Sall1 interact and co-localise in mouse F9 teratocarcinoma cells. 
• Sall4-Sall1 interaction on the genetic level was demonstrated by crossing experiments. 
The number of double heterozygous Sall1/Sall4 offspring was significantly reduced.  
 
4.1 Sall4 expression analysis 
 
It was previously reported that Sall4 consists only of four exons and has one transcript variant 
(Kohlhase et al., 2002b). In the mammalian SALL family alternative splicing was previously 
described for mouse Sall2 (Kohlhase et al., 2000b), human SALL2 (Ma et al., 2001), Msal-1 
(Sall3) and human SALL3 (Ott et al., 2001, Kohlhase et al., 1999b). Evidence is provided here 
for the existence of alternative splice variants for the murine Sall4 gene. Four mRNA isoforms 
(Sall4 major, Sall4 minor, Sall4 isoforms b, Sall4 isoform c) are produced by alternative 
splicing of Sall4. Database analysis suggested the presence of an additional exon 1a in Sall4 
gene. Analysis of embryonic mRNA by RT-PCR confirmed that exon1 and exon 1a are 
utilised in the production of two distinct transcripts (Fig. 3.4). Two additional alternative Sall4 
transcripts were reported in the database. In the Sall4 isoform b and isoform c 3' part of exon 2 
and complete exon 2 are skipped, respectively (Fig. 3.6). 
Polyclonal anti-Sall4 antibody generated in the present study was raised against C-terminal 
domain (360 aa) of Sall4 and should detect all isoforms.  However, Western blot analysis 
revealed only one single band of 113 kDa corresponding to the predicted size of the Sall4 
major transcript (Fig. 3.22). Probably due to the small protein size difference between Sall4 
major and minor it is not possible to detect Sall4 minor transcript. It remains to be proven 
whether isoform b and isoform c lead to functional proteins or whether they have tissue 
specific or different temporal expression pattern. 
Sall4 major transcript includes exon 1 and is expressed as early as E7.5 together with Sall4 
minor (Fig. 3.10). Expression of Sall4 minor with exon 1a is restricted to the E14.5 stage 
while the Sall4 major transcript is expressed until E16.5. However, the expression of exon 2-4 
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transcript which detects both variants was detectable until E16.5. Overall during embryonic 
development the expression level of Sall4 decreases. This observation could imply an 
important role of Sall4 in initial steps of development like gastrulation and early 
organogenesis. The contribution of the two transcript variants to the Sall4 expression level is 
not equal. The presence of two different regulatory elements which control the expression of 
Sall4 major and Sall4 minor could be proposed. The presence of two distinct tissue specific 
promoters to control transcription of SALL2 splice variants was shown by Ma et al. (2001). 
They demonstrated that the P1 promoter exhibits a weaker activity only in the thymus, testis 
and colon, whereas P2 activity was significantly higher in the wide spectrum of tissues like 
fetal liver, leukocytes, thymus, tonsil, spleen, colon, prostate and testis (Ma et al., 2001). In 
conclusion, it has to be confirmed by additional experiments if alternative Sall4 promoters 
exist, and which role they play in the tissue specific and stage specific expression of Sall4. 
By X-gal staining, Sall4 expression was detected in preimplantation stage embryos at the 
blastocyst stage. Sall4 expression was observed in the inner cell mass of the embryo which 
gives rise to the three germ cell layers ectoderm, mesoderm and endoderm, and also in the 
trophectoderm cells which form extraembryonic tissues including placenta. Sall4 homozygous 
blastocysts look normal at E3.5 and after 5 days in culture which would imply that Sall4 is not 
required for trophectoderm formation. However, the observed Sall4 expression in 
trophectoderm might be sufficient to support trophectoderm differentiation on later 
developmental stages. This observation might play an important role in interpretation of the 
Sall4 mutant phenotype. 
Expression analysis in postimplantation embryos by means of X-gal staining revealed a 
pattern similar to the previously reported expression of Sall4 (Kohlhase et al., 2002b). During 
embryonic development the expression pattern of Sall4 in the nervous system, branchial 
arches and tail tip is comparable to the expression in the chick and Xenopus embryos 
(Barembaum and Bronner-Fraser, 2004, Neff et al., 2005). At E8.5 Sall4 is expressed in the 
medial part in neural epithelium and in the caudal dorsal neural tube. At later stages Sall4 
expression is confined to the midbrain region and mesenchyme of the limb buds. Limb 
expression was seen with all murine Sall genes (Buck et al., 2001, Kohlhase et al., 2002a, Ott 
et al., 1996, Kohlhase et al., 2002b). Sall4 as well as Xenopus XlSALL4 (Neff et al., 2005) is 
expressed transiently in limb bud mesenchyme. The Sall4 limb expression pattern is 
interesting in the light of observations that human SALL4 mutations also cause severe limb 
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malformations (Kohlhase et al., 2002b, Al-Baradie et al., 2002, Kohlhase et al., 2005). 
Therefore, Sall4 could be an important transcriptional regulator which involved in limb 
patterning and specification together with other Sall genes. 
 
4.2 Sall4 is required for early heart development 
 
In E7.5 embryos Sall4 expression was found in the cardiac crescent and on the sections of the 
mesoderm, the region of future myocardial plate. The heart arises from cells originated from 
anterior lateral plate of mesoderm, the bilateral heart fields (Cohen-Gould et al., 1996). 
Cardiomyocytes first appear in the cardiac crescent (Fig. 4.1). The endocardial tubes fuse in 
the ventral midline to form the tubular heart with arterial and venous pole. At the arterial pole 
of the heart, the outflow tract connects with the aortic arch arteries in the pharyngeal region. 
Recently, a population of myocardial precursor cells in chick and mouse embryos has been 
identified in pharyngeal mesoderm anterior to the early heart tube. This anterior heart-forming 
field gives rise to myocardium of the outflow region or arterial pole of the heart (Kelly et al., 
2002). In previous reports it was shown that Xenopus xsal-3, chicken csal1 and csal4, and 
mouse Sall1 and Sall3 are expressed in the heart or in the structures necessary for heart 
development. 
 
E7.5 E8.0 E8.5
AS
RV
LV
A
 
Figure 4.1: Stages of mouse cardiogenesis. The major heart forming field is shown in black. Bilateral 
mesodermal heart fields fuse in the ventral midline to form the tubular heart with arterial and venous pole. AS, 
atria sinus venosa; RV, right ventricle; LV, left ventricle; A, atria (modified from Zaffran et al., 2002).  
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Sall4 expression was notable in the neural crest cells migrating from the hindbrain of E8.5 
stage embryo. During the formation of the neural tube, the ectodermal cells which are at the 
junction of the neural plate form neural crest cells. Neural crest-derived cells have stem cell 
characteristics because they have the capacity to proliferate and differentiate into various types 
of the cells, including sensory and sympathetic neurons, glial cells in the PNS, and smooth 
muscle cells in the blood vessels (Hall, 2000, Gammilll and Bronner-Faser, 2003, Sakai et al., 
2005). In addition, there are contributions of neural crest cells to the wall of the aortic arches 
and the aorticopulmonary septum (Tomita et al., 2005). There is also a speculation that defects 
in neural crest cell migration might be involved in tetralogy of Fallot (Gittenberg-de Groot et 
al., 2005). Chicken csal4 is involved in specification of avian cranial neural crest cell lineages 
(Barembaum and Bronner-Fraser, 2004). Our observation that Sall4 is expressed in the 
branchial arches and migrating neural crest cells which play an essential role during early 
heart development is consistent with the finding that SALL4 mutations can also be associated 
with severe heart defects (Borozdin et al., 2004a). Therefore, Sall4 could be an important 
transcriptional regulator which plays an essential role during cardiogenesis. In conclusion, it 
remains to be proven how Sall4 contributes to the development of the heart and in which 
signalling pathways it is involved. 
 
4.3 Hypomorphic phenotype of Sall4 gene trap mice 
 
In the present study a mouse mutant for the Sall4 gene is described which was generated by a 
gene trap approach. Based on the observation that all of the SALL4 mutations in Okihiro 
syndrome mutations are predicted to cause SALL4 haploinsufficiency (Borozdin et al., 2004b), 
the Sall4 heterozygous mutant mice were expected to show at least some features similar to 
Okihiro syndrome patients which include defects of the upper limbs, heart defects, renal 
anomalies and a missing 6th cranial nerve or its nucleus. However, no phenotype was observed 
in the heterozygous mutants. They had normal appearance, and both male and female 
heterozygotes were fertile. No abnormalities of skeleton, brain, kidney, muscles and heart 
were found.  
There are several ways to interpret this finding. The gene trap vector integration site lies 
between exon 1 and exon 1a, and quantitative RT-PCR showed presence of the minor 
transcript of approximately 73% in heterozygous embryos and 45% in Sall4 homozygous 
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embryos as compared to wild type. The integration led to a reduction of the major transcript to 
42% in heterozygous embryos and down to 2% in Sall4 homozygous embryos. The expression 
level of exon 3-4 transcript which represents the total amount of transcript was reduced in 
heterozygous embryos to 50% and in homozygous embryos to 10%. This result indicates that 
the Sall4 major transcript is largely disrupted by the gene trap vector integration. Despite of a 
strong splice acceptor sequence in the gene trap vector associated with the LacZ reporter and 
polyadenylation signal, the residual amount of transcript (2%) in homozygous embryos can be 
explained by a “bypass” of the gene trap vector. Bypass of gene trap vector which results in 
hypomorphic allele was discussed by Shawlot et al. (1998).  
The Sall4 minor transcript is expressed in homozygous embryos, but the level is strongly 
reduced. It can be assumed that the integration interferes with a possible promoter upstream of 
exon 1a or isolates exon 1a from a promoter upstream of exon 1. It remains unclear if presence 
of about 50% of the Sall4 major and of 70% of Sall4 minor transcripts is sufficient to avoid 
phenotypic consequences. Taking in consideration that expression level of exon 3-4 transcript 
is highly decreased in homozygous embryos the contribution of Sall4 minor transcript variant 
in overall Sall4 expression profile seems very low. The deletion of Sall4 minor transcript 
could confirm the involvement of this transcript in phenotype of Sall4 mice. However, it is 
unclear if Sall4 haploinsufficiency would result in a phenotype at all.  
Some interesting results about molecular mechanisms of the disease and mouse models were 
obtained from Sall1 studies in human and mouse. It has been proposed that molecular 
mechanism of Townes-Brocks syndrome (TBS) is haploinsufficiency, because most of the 
SALL1 mutations lead to the premature termination codons (Kohlhase, 2000a, Botzenhart et 
al., 2005). The recent study on SALL1 deletions in human confirmed SALL1 
haploinsufficiency as one of the mechanism for TBS development (Borozdin et al., 2005). 
Nevertheless, mouse model for TBS with deletion of all zinc fingers, reported by 
Nishinakamura et al., failed to recapitulate TBS phenotype. Like Sall4 heterozygous mice, 
Sall1 heterozygotes did not display any abnormalities. In homozygous condition Sall1 
knockout mice revealed kidney agenesis or severe kidney dysgenesis, but not other changes in 
any organs (Nishinakamura et al., 2001). TBS causing mutations in SALL1 could also lead to a 
truncated protein with a dominant negative activity of the mutated protein (Kiefer et al., 2003, 
Sweetman et al., 2003). Based on this hypothesis another transgenic mouse model which 
mimics the phenotype of TBS patients was described by Kiefer et al. (2003). Heterozygous 
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mice, expressing Sall1 transcriptional repression domain and lacking the DNA binding domain 
recapitulate the abnormalities found in TBS patients (Kiefer et al., 2003). These studies 
demonstrated that haploinsufficiency of murine Sall1 could not lead to the phenotype similar 
to TBS, while haploinsufficiency of human SALL1 cause mild TBS phenotype. 
Sall4, Sall2 and Sall3 heterozygous mutants are indistinguishable from wild type animals 
(Sato et al., 2003, Parrish et al., 2004). Sall2 knockout mice did not reveal any abnormalities 
neither in homozygous nor in heterozygous animals suggesting a possible alternative 
mechanism of compensation by other Sall genes (Sato et al., 2003). Sall3 homozygous mutant 
mice do not survive because of inability to feed due to palate and epiglottis anomalies (Parrish 
et al., 2004). 
To summarise, mouse models for Sall genes with haploinsufficiency of all zinc fingers do not 
display any abnormalities in heterozygotes. Homozygous mutants, except Sall2, die shortly 
after birth (Sall1 and Sall3) or during early embryonic development (Sall4). Molecular 
mechanisms described for human syndromes (TBS and Okihiro syndrome) most probably are 
not fully applicable for mouse models because of differences in functions in mouse and 
human. 
 
4.4 Sall4 homozygous mutant mice die during embryonic development 
 
Genotyping analysis of the F2 generation of Sall4 mouse line revealed that distribution of the 
genotypes in newborns was deviated from the Mendelian inheritance. Failure to recover mice 
homozygous for the Sall4 mutation suggested that the gene is essential for embryonic 
development. No changes in cellular proliferation or developmental arrest in Sall4 
homozygous mutant embryos were found during the preimplantation period. By genotyping 
analysis we could demonstrate that homozygous embryos die around E7.5 (Table 3.3). At E3.5 
stage Sall4 homozygous embryos were indistinguishable from heterozygous or wild type 
littermates (Fig. 3.17). By E7.5, however, mutants could be easily distinguished from normal 
embryos. Mutant embryos lacked the development of primitive streak and extraembryonic 
cavities or membranes and exhibited morphology similar to E6.5 embryos (Fig. 3.14). At E8.5 
normal embryos have completed gastrulation and start with organogenesis. In contrast, 
mutants were smaller and severely delayed as compared to their littermates (Fig. 3.13). At 
E8.5 stage embryos the most severe phenotypic abnormalities were in the heart region. The 
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heart is the first organ to form during early embryogenesis and its circulatory function is 
critical for the viability of the mammalian embryo.  
Several signalling pathways are involved in the specification of the heart precursors including 
BMP, Wnt and FGF (Shi et al., 2000, Marvin et al., 2001, Lavine et al., 2005, Zaffran et al., 
2002).  Mouse models with severe heart defects such as knockout mice for Nkx2-5, Gata4, 
Hand1, or Tbx5 (Lyons et al., 1995, Narita et al., 1997, Srivastava et al., 1997, Bruneau et al., 
2001) die during early gestation period because of heart failure. In Nkx2-5 mutant embryos, 
the heart tube formation occurs normally, but looping morphogenesis is not initiated at the 
linear heart tube stage (E8.25-E8.5) (Lyons et al., 1995). Gata4 knockout mice die by E9.5 
and exhibit profound defects in ventral morphogenesis, including abnormal foregut formation 
and a failure of fusion of the bilateral myocardial primordial fields (Narita et al., 1997). The 
embryonic lethality of Sall4 homozygous mutant embryos during early gestation could 
therefore result from cardiac bifida together with the deformation of the foregut and missing 
neural tube closure. At the same time cardiogenic defects are unlikely to be a result of a 
general delay in the growth and development of Sall4 mutant embryos. The embryonic death 
because of heart failure occurs in later stages, starting from E8.25. Another possibility would 
be that the cardiac defects could be secondary to insufficient nutrition because of 
abnormalities of the developing placenta or the ectoplacental cone. A support for this 
hypothesis could be that Sall4 is expressed during blastocyst stage in the trophoblast which 
later gives rise to the embryonic part of the placenta and ectoplacental cone. A similar mouse 
model was described by Firulli et al. (1998). Homozygous Hand1 mutant embryos die around 
E8.5 because of yolk sac abnormalities combined with heart defects. It might therefore well be 
that Sall4 homozygous embryos are developmentally delayed and die around E7.5 of heart 
failure, foregut deformation and open neural tube. The possible contribution of an 
extraembryonic component to the Sall4 phenotype remains to be investigated. 
 
4.5 Sall4 regulation during embryonic development 
 
Previous analysis showed that the expression of D. melanogaster sal and salr genes in the 
wing imaginal disc is under direct regulation by the TGF-ß molecule Dpp, ortholog of 
vertebrate BMP family (de Celis et al., 1996). During sensory organ development sal/salr 
expression is regulated by the signalling molecules hedgehog (hh), wingless (wnt) and 
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decapentaplegic (dpp) (de Celis et al., 1999). It was also found that sal is downstream of the 
wingless signal in the Drosophila tracheal system (Chihara and Hayashi, 2000). Medaka sal 
expression was found in all known hh signaling centres and appears to be a general target of 
hh in the medaka fish (Köster et al., 1997). Chicken csal1 expression in the developing limbs 
is dependent on Shh signals and also is regulated by molecules of FGF and Wnt signalling 
pathways (Farrel et al., 2000). 
To study the mechanism through which sall genes carry out these functions several 
downstream targets for sall proteins were identified in D. melanogaster. sal inhibits expression 
of iriduois and kni in the developing veins (de Celis et a, 2000). C. elegans homologue sem-4 
represses the activity of Hox genes mec-3 and egl-5 through binding to the promoter regions 
of these genes (Toker et al., 2003). In Sall1-deficient mice remarkable downregulation of 
some kidney mesenchymal markers like BMP7, Wnt4 and Pax2 was observed (Nishinakamura 
et al., 2001). Murine Sall1 interacts with HDAC components and strongly repress the 
transcription in the luciferase reporter assay (Kiefer et al., 2002). Sall1 can also interact with 
UBE2I and undergoes covalent modification with SUMO-1 molecules (Netzer et al., 2002). 
Sall1 can synergistically enhance reporter activity of the Wnt pathway (Sato et al., 2004). 
Human SALL1 repression function is mediated through the interaction with PIN2/TRF1 
(Netzer et al., 2001). These experiments have demonstrated that SALL proteins are 
transcriptional repressors and most probably inhibit their downstream targets directly. 
Identification of downstream targets of Sall4 is important for an understanding of the 
phenotype of Sall4 mutant mice. The expression pattern of several well known molecular 
markers which expressed during early embryogenesis was examined. At E8.5 Pax3 is 
expressed in the neural tube and by pre-migratory neural crest cells (Goulding et al., 1991) and 
loss of Pax3 leads to the spina bifida phenotype and displays cardiac outflow abnormalities 
and defective melanocyte development (Epstein et al., 1991). Sall4 homozygous embryos did 
not express Pax3 (Fig. 3.18). A possible explanation for the lack of Pax3 expression is that 
mutant embryos in their development do not reach the stage when Pax3 expression initiates. 
At the same time Pax3 expression pattern and influence on the migration behaviour of cardiac 
neural crest cell (Epstein et al., 2000) fits with the expression pattern and heart phenotype of 
Sall4 mice. Sall4 phenotype is more severe than Pax3 and occurs earlier. From this 
observation it can be speculated that Pax3 expression might be controlled by Sall4. 
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The T-box gene (Tbx) family plays an essential role in controlling many aspects of 
embryogenesis. Mice homozygous for T-box gene brachyury die shortly after gastrulation 
because of complete loss of the posterior mesoderm (Wilkinson et al., 1990). Misregulation of 
brachyury expression in homozygous Sall4 embryos can be explained by developmental delay 
and abnormal gastrulation (Fig. 3.19C, D). The cells of the cardiogenic mesoderm are brought 
to the cardiac crescent by gastrulation movements (Zaffran et al., 2002) and misregulation of 
this mechanism could lead to heart formation failure. This result indicates that axis of the 
development is disrupted possibly because of problems in mesoderm formation.  
Several members of T-box family have been implicated in early cardiac lineage determination, 
chamber specification and valvuloseptal development (Chapman et al., 1996, Simon, 1999). 
Haploinsufficiency of human TBX1 leads to the DiGeorge syndrome (DGS) which comprises 
hypocalcaemia, thymic hypoplasia, and outflow tract defects of the heart with tetralogy of 
Fallot, truncus arteriosus, and ventricular septal defects (Yagi et al., 2003). Disturbance of 
cervical neural crest cell migration into the derivatives of the pharyngeal arches can account 
for the phenotype (Kochilas et al., 2002). Loss of Tbx1 in mice has been implicated in the 
etiology of cardiac outflow tract and pharyngeal arch anomalies (Merscher et al., 2001, Jerome 
et al., 2001). Mutations in human TBX5 are responsible for Holt-Oram syndrome (HOS) with 
highly variable phenotypes including both upper limb and cardiac defects (Basson et al., 
1999). There are overlapping clinical features between Okihiro syndrome and HOS. Mutations 
of SALL4 gene were reported in some HOS patients (Kohlhase et al., 2003). Absence of mouse 
Tbx5 causes embryonic lethality (E10.5) and aberration of cardiac development (Bruneau et 
al., 2001, Zhou et al., 2005). 
The expression profile of brachyury, Tbx1 and Tbx5 in Sall4 mice was analysed by real-time 
RT-PCR. Strong reduction in the expression level of all three T-box genes was observed in 
homozygous embryos. Expression of Tbx1 and Tbx5 was downregulated to around 6% of the 
wild type level, while brachyury expression was reduced by 45%. Expression of these genes 
was almost unaffected in Sall4 heterozygous embryos. This result indicates that T-box genes 
expression might be regulated by Sall4 and gene dosage is important for this regulation. Sall4 
function might be mediated through some other genes which interact with T-box genes 
directly, for example Gata4 or Nkx2.5 (Hatcher et al., 2003, Bruneau, 2002). Sall4 gene might 
be involved in some signalling pathways which play a role during neural crest cell migration 
and heart formation. Direct involvement of BMP, Wnt and FGF signaling in early 
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cardiogenesis was previously shown in Drosophila and vertebrates (Delot et al, 2003, Barron 
et al., 2000, Marvin et al., 2001). For example, BMP signals control several cardiac regulatory 
genes, which include Gata4 (Nemer et al., 2003) and Hand genes (Schlange et al., 2000). The 
regulation of Sall4 seems to be a complex process in which both transcriptional activators and 
repressors interact with particularly regulatory regions to exert the signals during specification 
and patterning of the heart. To summarise, we can propose a general model for Sall4 
regulation during cardiac formation (Fig. 4.2). BMP, FGF and Wnt pathways trigger the 
interaction of several cardiac transcription factors like Hand1, Hand2, Nkx2.5, Gata4, Tbx5. 
Sall4 might b involved in this cascade by regulating the activity of Tbx1 and Tbx5 genes. The 
essential role of Sall4 in this pathway, potential interaction partners and target genes might be 
studied in future. 
 
 
Figure 4.2: General pathway of cardiac transcription factors regulation. Signaling molecules of BMP, Wnt and 
FGF pathways mediate the cascade of the reactions which lead to the activation of the protein-protein interactions 
of cardiac transcription factors (TF). These complexes regulate transcriptional activity of the target genes. BMP, 
bone morphogenic protein, FGF, fibroblast growth factor, TF, transcription factor.  
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4.6 Future perspectives 
 
New Sall4 isoforms characterised in the present study address the function of these isoforms 
during embryonic development and in the adult tissues. By additional experiments the 
existence of an alternative promoter region for Sall4 minor transcript has to be confirmed and 
which role it plays in the tissue specific and stage specific expression of Sall4.  
Polyclonal anti-Sall4 antibody opens new possibilities in detecting novel protein-protein 
interactions as they can be used for the co-localisation and co-immunoprecipitation assays. 
The main purpose of these experiments is to find out new interaction partners and to expand 
the knowledge about the function of Sall4 and other Sall proteins in vivo. 
In the present study a hypomorphic Sall4 gene trap mouse line was characterised. Although 
the mutant Sall4 mice do not show similar phenotype to Okihiro syndrome, the hypomorphic 
mouse model gives the opportunity to study the role of Sall4 major transcript as transcriptional 
regulator which is involved in cardiac development. Overall developmental delay of Sall4 
homozygous embryos raises the question about possible contribution of an extraembryonic 
component to the Sall4 phenotype which can be investigated by additional markers or 
tetraploid rescue.  
To establish real mouse model for Okihiro syndrome some important points have to be 
considered. Sall4 gene has several isoforms and to get Sall4 loss-of-function all of them 
should be disrupted. New gene trap line with integrations in intron 2 and 3 or knockout 
strategy will be the necessary tool for this analysis. Another important point is that Sall4 
heterozygous mice are normal and phenotype of Sall4 homozygous mice is different from 
Okihiro syndrome features. This observation may suggest the compensation effect by other 
Sall genes. Deletion of other Sall family members in combination could overcome this 
problem and help to elucidate their functions. 
Of additional interest are the interaction studies of Sall4 with both Sall1 and truncated Sall1 
proteins. Both Sall4 and Sall1 are co-expressed during embryonic development in the 
primitive streak, brain, limbs and branchial arches (Buck et al., 2001, Kohlhase et al., 2002b). 
From previous studies it is known that some of the Sall family members can interact in vitro 
with other family members in mouse and chicken and form homo- and heterodimeric 
complexes (Kiefer et al., 2003, Sweetman et al., 2003). The important interaction domain with 
dominant negative activity was mapped to the N-terminal part of the Sall1 (Kiefer et al., 
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2003). It contains single zinc finger domain and the conserved glutamine-rich domain which is 
responsible for the interaction (Sweetman et al., 2003). Furthermore, it was found that 
truncated chicken csal1 and murine Sall1, similar to the truncated protein expressed in TBS 
patients, can interfere with normal function of full-length proteins by preventing the native 
proteins from localizing to the nucleus (Sweetman et al., 2003, Sato et al., 2004). Sall1 and 
truncated Sall1 proteins can bind specifically with all four Sall proteins, suggesting that this 
might be one of the Sall proteins function (Kiefer et al., 2003). 
Nuclear localisation of Sall4 in F9 cells is predicted by other Sall family members and 
probably localised to pericentromeric heterochromatin (Netzer et al., 2001, Kiefer et al., 2002, 
Sato et al., 2004). Transfection experiments with myc-tagged Sall1 truncated construct 
revealed a clear displacement of Sall4 protein from the nucleus and cytoplasmic co-
localisation with Sall1tr protein (Fig. 3.25). These preliminary studies suggest that dominant 
negative effect of Sall1tr can be also expanded to Sall4 protein. Another evidence of Sall4-
Sall1 interaction was provided from the breeding experiments of heterozygous mice from 
Sall4 gene trap line and Sall1 knockout mouse line (Buck, 2002). The obvious deviation from 
the Mendelian inheritance ratio of Sall1/Sall4 offspring reflects an interaction between two 
genes (Table 3.4). The amount of Sall1/Sall4 double heterozygous mice was not significant 
and could be explained by genetic background effect. The absence of double heterozygous 
Sall1/Sall4 mice indicates the synergistic functional role and interaction between Sall1 and 
Sall4 gene. The Sall4-Sall1 interaction studies presented in this work could not give 
conclusive evidence about the mechanism of interaction and which domains or regulatory 
elements of Sall4 protein are responsible for maintaining specific protein-protein interactions. 
Co-localisation and co-immunoprecipitation experiments of Sall4 with full length Sall1 and 
truncated Sall1 will confirm the specificity and affinity of the interaction. It will be also of 
great interest to verify Sall4 protein interaction with other Sall family members. This will help 
to check the hypothesis of compensating the function of Sall genes by other family members. 
To confirm Sall4-Sall1 interaction on the genetic level it is necessary to find out when double 
heterozygous Sall1/Sall4 mice are dying and what is the underlying cause of the lethality. 
There is also a clear need for further studies to confirm the reported involvement of Sall4 in 
the cardiac development regulation. Although the regulation of several important cardiac 
transcription factors by Sall4 was demonstrated, it remains to investigate additional upstream 
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and downstream genes and targets which are responsible for early cardiac formation. Sall4 
mouse gene trap line and real-time PCR could be the powerful tool in determining such genes. 
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5. SUMMARY 
 
In the present study the function of Sall4 gene was investigated. Mutations in human 
homologue SALL4 gene cause Okihiro syndrome, an autosomal dominant disorder 
characterised by radial ray abnormalities and Duane anomaly and some other anal, renal, 
cardiac, ear, foot malformations and hearing loss. All of the mutations in SALL4 lead to 
preterminal stop codons and are thought to cause the phenotype via haploinsufficiency. Up to 
now no mouse model for Sall4 gene was available. The main goal of this work was to 
characterize the mutation and the phenotype of the Sall4 gene trap mouse line which can 
reflect the possible mechanisms of development of human syndrome. 
Sall4 consists of 5 exons with ORF of 3203 bp. New splice variant Sall4 minor which utilises 
alternative exon 1a instead of exon 1 was characterised. Expression for both transcripts was 
detectable as early as E7.5 and gradually decreases until E17.5. The contribution of the two 
transcript variants to the Sall4 expression level is not equal. The presence of two different 
regulatory elements which control the expression of Sall4 major and Sall4 minor can be 
proposed. 
By X-gal staining Sall4 expression was detected in the blastocyst stage embryos in the inner 
cell mass and in the trophectoderm cells. During embryonic development Sall4 is expressed in 
the nervous system, branchial arches, limb buds and tail tip. In E7.5 embryos Sall4 expression 
was found in the cardiac crescent, the region of future myocardial plate. Sall4 expression was 
also notable in the migrating neural crest cells which are involved in generation of outflow 
tract of the heart. Therefore, Sall4 could be an important transcriptional regulator which plays 
an essential role during cardiogenesis.  
In order to establish an appropriate mouse model system for Okihiro syndrome and to study 
the function of Sall4 gene the gene trap ES cell line with pT1ßgeo gene trap vector integration 
between exon 1 and exon 1a was used to generate Sall4 mouse line. Quantitative RT-PCR 
showed that the Sall4 major transcript was largely disrupted by the gene trap vector integration 
while the Sall4 minor transcript is expressed in homozygous embryos, but the level is strongly 
reduced. No apparent phenotype was observed in the heterozygous mutants. Sall4 
homozygous embryos were developmentally delayed and die around E7.5 because of heart 
failure, foregut deformation and open neural tube. 
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Some downstream targets of Sall4 were used to describe the phenotype of Sall4 mutant mice. 
Sall4 homozygous embryos did not express Pax3, an early marker for neural epithelium, 
indicating that Pax3 expression might be controlled by Sall4. Misregulation of brachyury 
expression in homozygous Sall4 embryos can be explained by developmental delay and 
problems in gastrulation. The expression profile of T-box genes brachyury, Tbx1 and Tbx5 in 
Sall4 mice was analysed by real-time RT-PCR. Strong reduction of the expression level of all 
three T-box genes was observed in homozygous embryos; in contrast, the expression of these 
genes was almost unaffected in Sall4 heterozygous embryos. This result indicates that 
expression of T-box genes which are involved in early cardiogenesis might be regulated by 
Sall4 and gene dosage is important for this regulation. 
Sall4 can interact with other Sall family members. Transfection experiments with myc-tagged 
Sall1 truncated construct revealed a clear displacement of Sall4 protein from the nucleus and 
cytoplasmic co-localisation with truncated Sall1 protein. Another evidence of Sall4-Sall1 
interaction was provided by breeding experiments of heterozygous mice from Sall4 gene trap 
line and Sall1 knockout mouse line. The severe reduction of double heterozygous Sall1/Sall4 
mice indicates the synergistic functional role and interaction between Sall1 and Sall4 gene on 
the genetic level.  
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